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Abstract
Purpose: The aim of this study was to investigate the psychological impact of
diagnosis and surgery in the treatment of eariy stage breast cancer. It was predicted
that diagnosis of breast cancer would be associated with an acute stress reaction.
Better psychological adjustment one month after surgery was predicted for women who
had undergone breast-conserving surgery in comparison to patients who had received
a mastectomy. Suppression of negative emotion in response to breast cancer diagnosis
was predicted to be related to poorer short-term psychological adjustment.
Method: Twenty-nine women completed baseline psychological measures one week
after receiving a breast cancer diagnosis. Follow-up measures completed one month
after surgery were obtained in twenty five cases. Evidence of acute stress response
was measured using scores for intrusive distress and avoidance on the revised Impact
of Events Scale (IES, Horowitz, 1979). Psychological adjustment was assessed based
on several key factors described in the literature concerning the psychosocial outcome
of breast cancer: levels of psychological distress (anxiety and depression), measured
using the Hospital Anxiety and Depression Scale (HAD, Zigmond & Snaith, 1983);
coping responses obtained on the Mental Adjustment to Cancer Scale (MAC, Watson,
Greer, Young et al, 1988b), and body image satisfaction, assessed using the recently
developed Body Image Scale (BIS, Hopwood, Fletcher, Lee & Al Ghazal, 2001).
Suppression of negative emotion was indicated by scores for control of negative
emotion on an adapted version of the Basic Emotion Scale (Power, 2001).
Data analysis: Patient scores on psychological measures obtained one week after
diagnosis and at follow up one month post-surgery were compared using a within and
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between subjects repeated measures ANOVA. Patient age at diagnosis, and whether or
not they were referred through screening, were then re-entered as covariates within the
repeated measures design in post-hoc analyses. Backward multiple linear regression
was carried out to examine emotional suppression as a predictor of adjustment
assessed using the psychological measures completed at follow up post surgery.
Results: Evidence of acute stress response, indicated by clinical 'caseness' for
intrusion and avoidance on the IES, was found in 28% of the sample assessed soon
after diagnosis, with a proportion of patients (almost 20%) continuing to report high
levels of intrusive distress and avoidance at follow up one month after surgery. As
predicted, IES scores for intrusion and avoidance were significantly lower between
assessment soon after diagnosis and at follow up after surgery (F 1,23 = 13.37,
p<0.05). Consistent with previous reports in the literature, no effect was found for type
of surgery on any of the measures used. Women who were younger at the time of
diagnosis were, however, likely to be more anxious (F 1,23 = 4.48 p<0.05) and to
experience greater levels of intrusive distress ( F 1,23 = 4.86, p<0.05). Suppression of
negative in response to diagnosis predicted higher levels of intrusive distress and
avoidance at one month (F2,22 =6.24, POD.05, R2 =.36), and greater levels of
dissatisfaction with body image (F 1,22 = 7.74, p<0.05, R2 = 32). Results are discussed
in relation to the previous literature, and in terms of implications for aspects of
psychosocial care for breast cancer patients.
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1. Introduction
1.1. Breast Cancer
Breast Cancer- Facts and Figures
Breast cancer is common, affecting 1 in 12 women (Breast Cancer Care, 1998). In the
UK, breast cancer is the cause of 21,000 deaths each year, with prevalence rates for
the disease around five times higher than this figure (Dixon & Sainsbury, 1998). Risk of
breast cancer increases with age, and incidence is highest amongst women age 55-60.
A relatively small proportion of breast cancers (5-10%) are genetic. Two genes have
recently been identified (BRCA1 and BRCA2). The risk of developing breast cancer is
increased three to four times for women with a first degree relative (mother, sister) who
has the disease, and is higher still if the relative was younger (<50) when the disease
was first diagnosed. Several risk factors are currently under investigation, but as yet no
causal links have been established. These include environmental pollutants, smoking,
diet, influence of contraceptive hormones, and hormone replacement therapy (Dixon &
Sainsbury, 1998).
Disease Types
Breast cancer is not just one disease. There are two broad categories of breast cancer,
invasive carcinoma and carcinoma in situ (Breast Cancer Care, 1998). Breast cancer
arises within the terminal duct lobular unit. The most common type of breast cancer,
accounting for up to 85% of cases, is invasive carcinoma of no special type (NST),
often called invasive ductal carcinoma. Special types include invasive lobular
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carcinoma, invasive tubular, cribriform, medullary and mucinous, with other types being
less common. The prognosis is better for many of the special types. Carcinoma in situ
refers to carcinoma cells confined to within the terminal duct lobular unit and the
adjacent ducts, but which are not yet invaded through the basement membrane. Two
main types have been described - ductal carcinoma in situ (DCIS) and lobular
carcinoma in situ (LCIS).
Specialist Breast Care Units
Breast diseases, including breast cancer, are increasingly being treated at specialist
units where close cooperation between surgeons, pathologists, radiologists and other
medical staff allow rapid and accurate diagnosis with appropriate treatment to be
offered to patients (Dixon & Sainsbury, 1998). Specialist breast nurses are appointed to
all units dealing with breast diseases. Patients may be referred to specialist breast units
either by their GP or as a result of screening. In some areas, specialist units are
available within District General Hospitals, with patients required to travel to another
hospital only for radiotherapy.
Screening
It is hoped that earlier identification of breast cancers will increase for women in the
highest risk age group as a result of the National Breast Screening Programme (NBSP),
which currently entitles women aged 50-64 to screening every 3 years. Many more
patients with DCIS are now being diagnosed through breast screening, and it is hoped
that detection of these early lesions will reduce subsequent incidence of invasive
cancer (Dixon & Sainsbury, 1998).
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Staging Classifications
Once breast cancer is diagnosed the patient is staged. The Tumour size-Node-
Metastasis (TNM) classification is used. Tumour size and nodal status may change
when the definitive histological report is available, thus TNM classifications are used
clinically and should not be confused with pathological staging (Dixon & Sainsbury,
1998). Comparison of TNM and the older UICC classification still used sometimes is
shown in Table 1.1.
Early and Advanced Disease
Breast cancers are typically described as either 'early' (stage I or II) or 'advanced'
(stage III and IV) disease. This division is based on the criteria of 'operability'. The term
early has been described as a misnomer, since true early breast cancer would be too
small to detect (Dixon & Sainsbury, 1998). The term early therefore refers to the biology
of the tumour.
T Is in situ
T1 < 2cm (T1a< 0.5cm, T1b > 0.5 -1.0 cm, T1c > 1-2.0 cm)
T2 > 2-5 cm
T3 > 5cm
T4a involvement of chest wall
T4b involvement of skin (includes ulceration, direct infiltration, peau d'orange and satellite
nodules)
T4c a and b together
NO No regional node metastasis
N1 Mobile ipsilateral nodes
N2 Fixed ipsilateral nodes
N3 Internal mammary node involvement (rarely clinically detectable)
MO No evidence of metastasis
M1 Distant metastasis (includes ipsilateral supraclavicular nodes)
Correlation of UICC (1987) stage and TNM
Stage I = T1, NO, MO
Stage II = T1, N1, MO; T2, N0-1, MO
Stage III = any T, N2 or T 3, N1, MO or T4, NO-2, MO
Stage IV = any T, any N, M1




Survival of patients with breast cancer depends on two factors: tumour stage (reflecting
chronology, or how long the tumour has been present), and biological factors
representing the biology or aggressiveness of the tumour (Dixon & Sainsbury, 1998).
Routine prognostic factors include tumour size, histological grade (classified from l-lll
using the Bloom & Richardson system) and nodal status. Prognostic indicators are
important in selecting adjuvant therapies for individual patients. Patients may be
stratified based on the number of nodes involved, using tumour size and grade to
stratify the node negative group. The different risk groups identified using this method
and disease free survival rates at 5 years are shown in Table 1.2. Alternatively, a single
prognostic index may be used, such as the Nottingham Prognostic Index (NPI)
described below.
Risk Group Definition 5 yr disease free survival (%)
Node negative patients
o Low risk Tumour < 1 cm in diameter >90
o Intermediate risk Tumour > 1 cm, grade I or II 75-80
° High risk Tumour > 1cm, Grade III 0-60
Node-positive patients
° Low and intermediate risk 1-3 axillary nodes involved 40-50
° High risk 4-9 axillary nodes involved 20-30
o Very high risk > 10 axillary nodes involved 10-15
Table 1.2: Definitions of risk groups and associated disease free survival rates at 5 years
(Dixon & Sainsbury, 1998).
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Nottingham Prognostic Index
Tumour size, grade and nodal status may be combined to form a prognostic index
which allows greater separation of survival curves than for each factor alone. The
Nottingham Prognostic Index (NPI, Blarney, 1996) is the best known of these indices,
based on retrospective, multivariate analysis of hundreds of cases where survival and
time to relapse was well quantified, and confirmed by prospective application on a new
patient set and through long term follow up (Blarney, 1996). Tumour grade, lymph node
(LN) status (stage) and size are combined in the formula:
NPI = grade (measured 1-3) + LN stage (measured 1-3) + size (0.2 x size cm)
Thus, the higher the index, the worse the prognosis. Survival rates based on NPI values
are shown in Table 1.3.
PROGNOSTIC GROUP NPI VALUE 10 YEAR SURVIVAL (%)
EXCELLENT <2.4 94
GOOD <3.4 83
MODERATE I <4.4 70
MODERATE II <5.4 51
POOR >5.4 19
Table 1.3: Survival rates at 10 year for prognostic groups based on NPI values (Blarney,
1996)
Other biological markers
Other, newer biological factors related to the biology of the tumour have been identified
using special biochemical or immunohistochemical tests, but as yet not all of these are
in routine clinical use. Oestrogen receptors (ER) were the first of the biological markers
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to be studied. Approximately 60% of tumours contain detectable ER. Although the
difference in disease-free survival between those with node positive, ER tumours, and
node negative, ER tumours is small (5-10%), survival after first recurrence is predicted
by ER status, with ER positive patients living longer and having a better response to
adjuvant chemotherapy or hormone therapy. It is now therefore recommended that all
patients have their ER status estimated and recorded (Dixon & Sainsbury, 1998).
Treatment of Early Stage Breast Cancer
Treatment of patients with early stage breast cancer has two main goals - to achieve
local disease control, and to treat any micrometastic disease. Treatment for breast
cancer most often involves surgical removal of part or all of the breast. The resulting
disfigurement can be extremely distressing for some patients. There are two main
types of operation: partial mastectomy, ranging from lumpectomy (wide local excision),
in which the lump is removed together with small amounts of the surrounding tissue, to
segmentectomy or quanrantectomy, in which approximately quarter of the breast is
removed; and total mastectomy, in which all breast tissue is removed, usually either a
simple mastectomy, which removes breast tissue alone, or a modified radical
mastectomy, in which all breast tissue together with some chest muscle and some or all
of the lymph nodes are removed (Breast Cancer Care, 1998). As many as 50% of
women with early breast cancer will be cured either by surgery alone or in combination
with post-operative radiotherapy, therefore it is important to define these patients to
spare them further treatment (Dixon & Sainsbury, 1998). Adjuvant chemotherapy and/or
hormone therapies recommended for some women with operable breast cancers can,
8
however, reduce the annual risks of death by about 30% for at least 10 years (Early
Breast Trialists' Collaborative Group, 1992).
Psychosocial Outcome of Early Stage Breast Cancer
Improved methods of screening and diagnosis, and advances in treatment during the
last few decades have meant that increased numbers of patients with operable breast
cancer will now complete longer disease free intervals, with approximately 70%
surviving at 5 years and beyond (Dixon & Sainsbury 1998). Increased survival rates
have put new emphasis on quality of life for breast cancer patients, and on efforts to
improve the psychosocial outcome of the disease and its treatment (Fallowfield & Clark,
1991). Although the meaning of breast cancer diagnosis has changed in recent years
(Moyer & Salovey, 1997), breast cancer is an emotive subject, continuing to receive
substantial media attention (Tait, 1996). Coping with cancer, its treatment and
associated side effects and the consequent disruption to normal patterns of daily living
is traumatic, and may be expected to cause a number of psychosocial problems for
patients (Cull, Stewart & Altman, 1995). The literature concerning psychological
adjustment in patients with early stage disease will be reviewed in following sections.
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1.2. Psychological Impact of Breast Cancer Diagnosis
Reactions to Diagnosis
Reactions to cancer diagnosis vary considerably between individuals (Derogatis,
Morrow & Fetting, 1983; Stanton & Snider, 1993), but feelings of fear, anxiety, anger,
depression, and helplessness are common (Slevin, Nichols, Downer, et al 1996). Often,
patients find themselves thrown from a state of apparent good health through a series
of frightening transitions involving investigations and treatments with potentially
unpleasant side effects. Fears concerning recurrence, pain and death, and feelings of
loss of control and uncertainty are common (Bloom, 1982).
Emotional reaction to diagnosis of breast cancer and responses to various stages of
treatment may be conceptualised as a process of adjustment. Theoretical models that
applied to our understanding of this process are drawn from the literature on
psychological adjustment to traumatic stressors, and to the effects of chronic illness or
disease. The crisis intervention literature indicates that an important adaptation takes
place in the first four to six weeks following the crisis, after which there is a return to
normal function (Budin, 1998). It is important to detect patients who are not returning to
their normal level of functioning in order that appropriate help can be offered (Watson,
1991).
Psychological Response to Severe Stressors
Diagnosis of breast cancer represents a potentially severe stressor (Moyer & Salovey,
1997). As diagnosis involves an actual or perceived threat to life or well being, it is
considered to meet the criteria for traumatic stress as defined in DSM-IV (APA, 1994).
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Post-traumatic stress disorder (PTSD) is a disorder of adjustment that occurs in
response to a traumatic stressor. Most studies of PTSD have investigated the impact of
trauma in response to severe stressors such as war or combat exposure (King, King &
Fairbank, 1998), disaster (McFarlane & Papay, 1992; Ironson, Wynings, Schneiderman,
et al, 1997), burn injury (Perry, Difede, Musgni, et al, 1992), or rape (Foa, Rothbaum,
Riggs & Murdock, 1991). Severity of stressor is an important predictor of response
(Breslau & Davis, 1987), however, since not all individuals exposed to the same
stressor develop PTSD, other factors contribute to adjustment. These have been shown
to include premorbid adjustment and personality (McFarlane, 1988). Individual's
perception or appraisal of the event can influence both initial and long term reactions
(Green et al, 1985; Foa et al 1991). The importance of the individuals' response to the
stressor (fear, perceived threat to life or well-being, helplessness), in contrast to other
ratings of severity of trauma, is emphasised in DSM-IV. PTSD is characterised by three
groups of symptoms: intrusive re-experience (flashbacks, dreams or recurrent
memories of trauma, intrusive thoughts); avoidance of reminders of the event, or
emotional numbing; and autonomic over-arousal (sleep disturbance, hypervigilance,
exaggerated startle response). Diagnosis of PTSD is made if symptoms are present for
more than one month. If symptoms present within the first month after exposure to a
stressor occurring, acute stress response may be diagnosed.
Traumatic Stress in Response to Life-Threatening Disease
Several reports suggest a link between life-threatening illness or highly stressful
medical procedures and the development of traumatic stress reactions in some medical
populations. These include burns patients (Powers, Cruse, Daniels & Stevens, 1994)
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and individuals experiencing cardiac events such as myocardial infarction, heart
catheterisation, or coronary artery bypass surgery (Doerfler, Pbert & DeCosimo, 1994;
Kutz, Shabtai, Solomon, Neumann & David, 1994). Only a few studies have
investigated post traumatic stress symptoms in cancer patients. Intrusive thoughts
concerning bone-marrow transplantation (BMT) and avoidance of reminders of
treatment have been reported in paediatric BMT patients (Heiney, Neuberg, Myers &
Bergman, 1994; Stuber, Nader, Yasuda, Pynoos & Cohen, 1991). PTSD-like symptoms
have been reported in acute leukaemia patients who had undergone either BMT or
conventional antileukemic therapy (Leskon, Ostroff, Mumma et al, 1992). In a study of
male patients with Hodgkin's disease, Cella & Tross (1986) found that survivors of the
disease showed more avoidant thinking about illness than healthy control patients. In
another study of individuals with Hodgkin's disease, intrusive thoughts and avoidance of
treatment reminders were inversely related to length of time since treatment completion
(Kornblith, Anderson, Cella et al, 1992).
Acute Stress Reactions associated with Diagnosis of Breast Cancer
One or two studies have recently examined adjustment in breast cancer patients from
a PTSD viewpoint. Acute Stress Response is described in a consecutive sample of 106
stage I and II breast cancer patients in Norway by Tjemsland et al (1996). Patients were
assessed shortly after diagnosis (before surgery). Using the Impact of Events Scale
(IES), nearly half of the patients (44%) reported high intrusive distress. Highest levels
were found in younger, married patients. Patients with previous experience of breast
cancer in a first degree relative tended to suffer less intrusive distress. Twenty-eight
percent of patients received breast conserving treatment (breast conserving surgery
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plus radiotherapy), although results for the whole sample were discussed together.
Follow up was carried out 6 weeks post operatively, at which time almost all of the
patients allocated to adjuvant treatment (39% chemotherapy, 52% endocrine therapy,
42% radiotherapy) had started this treatment. Intrusive distress at follow up was
significantly lower than pre-surgery. At follow up, only 8% of patients reached levels of
clinical 'caseness' on measures of both intrusive distress and avoidance. Potential
predictor variables assessed before surgery included impairments in work, family and
social functioning in the last year, negative life events in the last year, and health
problems in the last 10 years. None of these variables was found to be statistically
significant, although there was a trend for higher scores to be associated with more
reported health problems in the previous 10 years. One third of the patients identified as
possible PTSD at 6 week follow up had previously consulted their doctor for 'nervous
problems'. Trauma studies in other populations have underlined the importance of
premorbid factors in predicting subsequent adjustment, and suggest that response 4-6
weeks after the event is a better predictor than immediate response (Budin, 1998).
Adjustment over time
Cordova, Andrykowski, Kenady et al (1995) investigated PTSD-like symptoms in 55
breast cancer patients 6 months to 5 years post-treatment. Using a PTSD checklist
corresponding to DSM-IV criteria (PCL-C, civilian version), and the Impact of Events
Scale (IES), 5-10% of this sample were found to meet the diagnostic criteria for PTSD.
Evidence of PTSD symptoms was associated with generally poorer quality of life, and
was more commonly found in younger patients with lower incomes. Time since
treatment, type of cytotoxic treatment, and stage of disease were unrelated to PTSD
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symptoms. It is possible that the prevalence of PTSD in this sample is no different from
that found in the general population. Dansky, Saunders & Best (1993) reported similar
base rates of 4.6% in the previous 6 months, and a lifetime prevalence of 12.6% in an
unselected sample of 4,000 women (mean age = 45 years). Specific PTSD-like
symptoms may however be linked to aspects of diagnosis and treatment of cancer. For
example, 49% of patients included in the Cordova, Andrykowski, Kenady et al (1995)
study reported that they experienced recurrent, disturbing memories of cancer
treatment, the most common of these related to side effects of surgery or
chemotherapy. Physical anxiety reactions (nausea, palpitations, feelings of panic) when
reminded of the cancer or of cancer treatment were reported in 35% of the sample.
Prominent triggers were being in or near the hospital where they underwent treatment,
and thoughts about treatment or recurrence. Although at 6 month follow up very few
patients reached caseness on IES, frequently endorsed IES items included feelings of
unreality (71%) and numbness (41%). Half of the patients reported trouble falling or
staying asleep because of thoughts or pictures about their illness popping into their
mind, and 1 in 4 reported bad dreams as a result. 1 in 2 patients reported that they
avoided talking about their illness.
Traumatic Stress associated with Disease Recurrence
Stress response symptoms shortly after recurrence are reported by Cella, Mahon &
Donovan (1990) for a sample of 40 cancer patients undergoing chemotherapy. The
majority of patients in their sample showed evidence of high levels of avoidance
symptoms, and almost half showed a high level of intrusive symptoms. The extent to
which unpreparedness for recurrence predicted stress response symptoms was
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investigated by the authors of this study. Those patients who reported a balanced
concern about recurrence were found to be less prone to intrusive distress compared to
patients who were either completely or not at all surprised by the recurrence. Greater
intrusive distress was also reported amongst patients with first recurrence compared to
those with two or more recurrences, suggesting that high levels of intrusive distress
may be associated with recurrence. Similarly, Kaasa et al (1993), in their multi-centre
study of 247 cancer patients (23% breast cancer) undergoing radiotherapy for
recurrence in advanced disease, report that one-third of sample were above cut-off for
intrusion and avoidance, closer to the acute response described in the Tjemsland et al
(1995) study. Rates of psychological distress following recurrence of disease may be
higher than observed after diagnosis of cancer (Alexander et al 1993; Cella et al 1990;
Derogatis et al, 1983; Okamura et al; 2000; Silverfarb et al 1980). In their consecutive
sample of 55 women with first recurrence of disease, Okamura et al (2000) found that
42% of the sample assessed 3 months after recurrence was confirmed met DSM
criteria for major depressive disorder (7%) or adjustment disorders (35%). Disease free
intervals of less than 24 months predicted diagnosis of psychiatric disorder. Since
disease free interval is one of the most important prognostic indicators (Robertson et al
1992; Yamamoto 1998), earlier recurrence therefore indicated poorer prognosis.
Younger age (< 50) and concurrent chemotherapy treatment were also associated with
greater psychological distress.
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1.3. Longer-term Psychological Effects of Breast Cancer
During the period from discovery of a lump to hearing the diagnosis and having the
operation, thoughts and coping resources may be centred on coping with what is seen
as an immediate threat to life, and the physical recovery from the operation. Longer
term implications including worries about recurrence, body image, or reaction of partner
to breast cancer treatment may not be considered until after the patient returns home
from hospital and starts to feel physically better, at which point some women may begin
to feel emotionally worse (Fallowfield & Clark, 1991). Although diagnosis of breast
cancer initially evokes responses of grief, anger and intense fear, 'most women face the
crisis and master it without major psychological disorder or sexual dysfunction'
(Schover, 1991).
Anxiety and Depression
Depression and anxiety are the most commonly reported reactions to breast cancer.
Earlier reports indicated high levels of psychological problems in breast cancer patients
(Maguire, Lee & Bevington, 1978 Morris , Greer & White, 1977; Kemeny, Wellisch &
Schain, 1988; Meyer & Apergren, 1989; Schain, Edwards, Gorrell et al, 1983). More
recent studies suggest that the majority of women do not experience long term
emotional distress, and psychological adjustment improves over time (Irvine, Brown,
Crooks et al, 1991). Several reports indicate that levels of distress following diagnosis
and treatment of breast cancer are lower than previously reported (Carver, Pozo, Harris
et al 1993; Cella, Tross, Orav et al 1989; Penman, Bloom, Fotopoulis et al 1986;
Stanton & Snider, 1993; Wolberg, Romsaas, Tanner & Malec, 1989), or no different
from women treated for other types of cancers or in the general population (Worden &
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Weisman, 1977; Lansky, List, Hermann et al, 1985). Some of this distress might
therefore be transient, with only a small number of women experiencing unremitting and
substantial morbidity (Baider, Rizel & Kaplan De-Nour, 1986; Bloom, Cook, Fotopoulis
et al, 1987; Fallowfield & Clark, 1991).
Problems Determining Levels of Distress in Breast Cancer Patients
There are particular difficulties in determining levels of distress in breast cancer patients
(Moyer & Salovey, 1997). For example, symptoms of depression such as sleep and
appetite disturbance, inability to concentrate, apathy and loss of interest in usual
activities may be confounded with those resulting from cancer treatment (Wellisch,
1988). Psychiatric labels might therefore wrongly be assigned to cancer patients
(Peterson, 1984; Turk & Salovey, 1985). It has been suggested that indicators of
depression in breast cancer patients might therefore be those symptoms considered
more psychological such as feelings of worthlessness, extreme irritability, and recurrent
thoughts of suicide and death as well as sleep problems, concentration difficulties and
loss of interest in activities (Wellisch, 1988; Maguire, Lee & Bevington, 1978).
A second problem in examining distress associated with breast cancer is that anxiety
and depression have tended to be assessed using self-report measures only, and many
of the studies have failed to use common diagnostic criteria (Moyer & Salovey, 1997).
The available studies have tended to assess patients at different stages in treatment
(Wellisch, 1988), and have often used relatively small samples (Lansky, List, Hermann
et al, 1985), presenting further difficulties with interpretation of findings. Psychological
morbidity varies across studies according to the method and timing of assessments
(Carroll, 1998). However, psychological distress may continue long after treatment is
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completed (Watson, 1991). Longer term emotional problems such as depression,
anxiety and hostility have all been described in the literature, as well as low self esteem
and a decreased sense of personal control (Rabinowitz, 1997).
Psychological Impact of Breast Cancer on Body Image and Sexuality
Because of its impact on women's body image and sexual identity, breast cancer is
thought to be uniquely threatening to the self-concept and psychological integrity
(Moyer & Salovey, 1997). Derogatis (1986) proposes that body image and sexual
functioning are separate but integrally related components of self-image and of
psychological adjustment. Changes in body image following mastectomy are well
documented in the literature (Bloom, Cook, Fotopoulis et al, 1987; Golden, 1983; de
Haes & Welvart, 1985; Hopwood & Maguire, 1988; Margolis, Goodman & Rubin, 1990;
Polivy, 1977). The only consistent finding across studies comparing psychosocial
outcome of breast conserving therapy (BCT) with mastectomy (reviewed in a later
section) is for advantages of BCT in terms of body image (Moyer, 1997). This finding
appears to be consistent despite body image being assessed in a number of different
ways: feelings about physical appearance and sexual desirability; shame and
embarrassment about one's body; and measures of body image. Since BCT involves
less physical mutilation than mastectomy, the finding that it results in better body image
satisfaction is, however, considered circular by some researchers (Hall & Fallowfield,
1989). To the extent that body image may have a significant impact on psychological
adjustment for some women this effect may be not be trivial (Moyer & Salovey, 1997)
Breast reconstruction offers a way to improve body integrity and possibly adjustment
after mastectomy (Moyer, 1997) and can even result in cosmetic outcomes superior to
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those of breast conserving surgery (Cady & Stone, 1990; Taylor, Lichtman, Wood et al
1985). Level of satisfaction with body image amongst women who undergo
reconstruction after mastectomy is reported to fall between that of women treated with
mastectomy without reconstruction and women who receive breast-conserving surgery
(Mock, 1993; Wellisch, DiMatteo, Silverstein et al 1989).
Due to our cultural association of the breast with femininity and sexuality, loss or
disfigurement can threaten women's sense of attractiveness, and may alter sexual
relations (Moyer, 1997). Altered body image is likely to affect feelings of sexual
desirability and confidence, however, problems in sexual relationships while one partner
is being treated for cancer 'can result form reasons other than disfiguring effects of
surgery' (Moyer & Salovey, 1997). Studies investigating sexual difficulties have
suggested that as many as one third of patients report specific sexual problems
(decreased frequency of intercourse or difficulties with orgasm) after treatment for
breast cancer (Anderson & Johimsen, 1985; Bransfield, 1983). Sexual functioning is
dependent on many variables however. For example, women experiencing sexual
difficulties at three months post-surgery have been reported to show evidence of
greater psychological distress (anxiety, depression) and poorer overall adjustment
(Schover, 1991). Premorbid sexual functioning is likely be highly relevant, and may
predict sexual dysfunction after treatment. Yurek, Farrar & Anderson (2000)
investigated the sexual and body change sequelae in 190 women diagnosed and
surgically treated for regional breast cancer. The study compared three surgical groups:
mastectomy with breast reconstruction, mastectomy without reconstruction, and BCT.
Increased risk of sexual dysfunction and body image dissatisfaction post-operatively
was found in post-menopausal women receiving mastectomy, with or without
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reconstruction, and amongst women who showed evidence of negative sexual
schemas. The stage of treatment at which women are investigated may be a crucial
factor. Adjuvant radiotherapy contributes to fatigue and loss of libido, thus disrupting
sexual functioning in the first 12 months or so following surgery (Schover, 1991). For
women receiving chemotherapy, in addition to hair loss that can make one feel
unattractive, other side effects such as fatigue and nausea can reduce sexual interest
(Halifin, Althausen, Goldstein, et al 1990). The experience of physical pain is also
related to problems relaxing and in enjoying physical intimacy. Fear and feelings of
depression and anger experienced during the course of treatment may also contribute
to lack of interest in intimacy in addition to disfigurement or effects of adjuvant treatment
(Moyer & Salovey, 1997). Comparisons of sexual satisfaction between breast cancer
patients and healthy controls may therefore be confounded by functional restrictions
resulting from the disease and its treatment (Beckham & Godding, 1990).
Cancer Related Fears and Concerns
Whereas early studies suggested that fear of losing the breast was the primary cause of
distress, more recent work has shown that fear of cancer rather than concern about the
effect of surgery is the primary reason for distress. It is suggested by Schain, d'Angelo,
Dunn et al (1994), that it is only since the use of breast conservation therapy has
become widespread that 'we have begun to factor out the relative contribution of the
type of surgery, rather than the diagnosis of life threatening disease, to the
psychological adjustment of women with breast cancer'. For example, in their sample
of 269 women, Fallowfield et al (1990) found that only 12% of women gave breast loss
as their primary focus of concern, with 59% more distressed at the prospect of having
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cancer. Fears about cancer recurrence and death are often identified amongst women
treated for breast cancer (Ganz, Schag, Polinsky et al 1987; Jones & Greenwood).
Disfigurement associated with mastectomy may remind women of the threat of cancer
(Aaronson , Bartelink, van Dongen & van Dam, 1988). On the other hand, women
treated with breast-conserving surgery may worry more about cancer returning because
less of the breast has been removed or had doubts about the effectiveness of breast
conserving treatments (Fallowfield et al 1986; Massie & Holland, 1991; Ward, Heidrich
& Wolberg, 1989).
Impact of Breast Cancer on Family and Social Functioning
The impact of breast cancer extends beyond the patient to her partner, family and
social network (Northouse, Cracchiolo-Caraway & Appel, 1991). There is evidence that
some husbands experience considerable distress when their partner is diagnosed and
treated for breast cancer (Baider & Kaplan de Nour, 1984; Zahlis & Shands, 1993)
irrespective of type of surgery received (Omne-Ponten, Holmberg, Bergstrom et al
1991). The importance of the partner's involvement in the treatment decision-making
process has been highlighted, and spouses who are involved have been shown to
report better sexual satisfaction both before and after surgery (Holland & Rowland,
1990). Involving partners in giving information about what to expect during the course of
treatment is helpful in reducing the feelings of helplessness than can often be reported
by partners (Northouse & Peters-Golden, 1993). Dealing with the uncertainty, as well as
the physical and psychological effects of breast cancer treatment can be stressful and
disruptive for families and may influence work, financial, or other family plans (Hilton,
1993). Positive consequences have also been documented however, including
increased closeness and caring within the family, family members becoming more
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helpful, and learning that others cared about them (Zemore, Rinholm, Shepel &
Richards, 1989). Family functioning appears to be related to marital functioning and
communication which facilitates the use of constructive family problem-solving
processes, whereas poor marital functioning negatively affects families coping (Lewis,
Woods, Hough & Bensley, 1989). With regard to support from the wider social network,
there are some reports of inadequate support being provided, or of failure of others to
understand that issues of survival had superceded cosmetic concerns (Peters-Golden,
1982). Other studies have indicated that patients report increased rather than reduced
social support from family and friends (Zemore & Shepel, 1989). Assessment of
patients levels of social support, and the perceived quality of this support is therefore
important.
Factors Influencing Psychosocial Outcome of Breast Cancer
The psychosocial outcome of breast cancer is influenced by a number of disease and
treatment related variables, as well as individual patient factors. These are discussed in
detail in the following sections.
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1.4 Influence of Disease Stage and Recurrence on the
Psychosocial Outcome of Breast Cancer
Disease Stage
Prevalence of psychological distress in cancer patients depends on many factors
beyond diagnosis. The majority of studies have investigated depression and anxiety in
patients with early stage disease. It has been suggested that psychological morbidity
may be lower in women with screen detected breast cancer (Farmer, Payne & Royle,
1995). Reasons for this are suggested as due to women receiving more reassurance of
an early diagnosis and treatment, 'while the benefits of screening are emphasised,
along with a conceptual model of early, curable disease' (Caroll, 1998). There has been
limited research on patients with more advanced disease. Pinder, Ramirez, Black et al
(1993) report that 25% of patients with advanced breast cancer obtained clinically
significant scores for either depression or anxiety using the Hospital Anxiety and
Depression Scale (HAD), a measure which excludes most symptoms that may result
from physical illness or treatment. Poor functional status was strongly associated with
depression in this study. At least one other study (Hopwood, Howell & Maguire, 1991)
reports similar findings. Previous work that included patients with other cancers
(Derogatis, Morrow & Fetting et al 1983) also reported high prevalence of psychological
disorder associated with poor prognosis and advanced tumour status. Stage of disease
or associated complications (e.g. pain, effects of treatment), the presence or absence of
metastases, particularly in the central nervous system, and functional physical status
may significantly influence occurrence of psychological distress in cancer patients
(Derogatis, 1986).
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The prognosis for cancer patients is influenced by several factors including disease
type, stage, and location. Using these three criteria, the American Psychological
Association (1992) distinguish three risk groups for developing psychological morbidity
(low, medium, and high), shown in Table 1.4. When disease is localised and controlled,
risk of psychological morbidity is low, and emotional reactions tend to stabilise over the
first year. In patients with regional disease, psychological adjustment is variable and
adjuvant therapies themselves may increase experience of distress. In systemic or
aggressive disease, psychological morbidity is higher. Interventions with patients in this
group tend to focus on adjustment to disease and existential issues.
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Table 1.4: Risk of psychological morbidity associated with disease prognosis (American
Psychological Association, 1992)
Recurrence
Rates of psychological distress following recurrence of disease may be higher than
observed after diagnosis of cancer (Alexander, Dinesh & Vidyasagar, 1993; Cella,
Mahon & Donovan, 1990; Derogatis et al, 1983; Okamura , Watanabe, Narabayashi, et
al; 2000; Silverfarb, Maurer & Crouthamel, 1980). In their consecutive sample of 55
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women with first recurrence of disease, Okamura, Watanabe, Narabayashi et al (2000)
found that 42% of the sample assessed 3 months after recurrence was confirmed met
DSM criteria for major depressive disorder (7%) or adjustment disorders (35%).
Disease free intervals of less than 24 months predicted diagnosis of psychiatric
disorder. Since disease free interval is one of the most important prognostic indicators
(Robertson, Dixon, Nicholson et al, 1992; Yamamoto, Watanabe, Katsumata et al,
1998), earlier recurrence therefore indicated poorer prognosis. Younger age (< 50) and
concurrent chemotherapy treatment were also associated with greater psychological
distress.
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1.5. Psychological Effects of Surgery in the Treatment of Early
Stage Breast Cancer
Historical Perspective
The earliest reports of psychological reactions to breast cancer were published in the
1950's. In their now seminal papers, Bard & Sutherland (1955) and Renneker & Cutler
(1952) described the responses of women who had undergone radical surgery, for
whom removal of the breast was considered to be the main cause of psychological
distress, in particular depression. These early reports were important in first drawing
attention to the psychological problems of distorted body image, anxiety and depression
associated with breast cancer treatment, and challenged the then prevailing view that
patients would simply adjust over time after 'removal' of the cancer. The early accounts
were, though, largely anecdotal, and were based on reports of women who had
undergone radical mastectomy, involving removal of the breast and underlying muscles
leaving a deformed chest wall. Previously, women discovering a breast lump faced just
one option: biopsy, and if indicated, radical mastectomy. As this was usually carried out
in a single procedure, women would often discover whether or not a breast had been
removed only upon wakening from their operation (Moyer & Salovey, 1997). Today, a
two stage procedure is used, with biopsy carried out prior to surgery. Breast conserving
surgery is available, and there are options for reconstruction following mastectomy.
Studies Comparing the Psychosocial Outcome of BCT with Mastectomy
As breast conserving therapy (BCT) became more widely available, studies comparing
the psychosocial outcome of BCT with mastectomy emerged. Over 40 studies have
now been carried out comparing the psychosocial outcome of breast conserving
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therapy (BCT) with mastectomy (Mx), summarised in Table 1.5. The earlier studies
(Sanger & Rezinkoff, 1981; Beckman, Johansen, Richardt & Blichert-Toft, 1983;
Schain, Edwards, Gorrell et al, 1983; Meyer & Aspergen, 1989) typically used small
samples (N <40) and were based on retrospective follow-up of patients at various
stages post-surgery. These studies found no significant difference in overall
psychological adjustment, with the only difference between BCT and Mx groups found
in relation to feelings about body image, which were better in BCT groups. Subsequent
studies using larger samples (Fallowfield, Baum & Maguire, 1986; Kemeny, Wellisch &
Schain, 1988; Lasry, Margolese, Poisson et al 1987; Ganz, Schag, Lee, et al 1992),
and a number of well designed, prospective studies (Pozo, Carver, Noriega et al 1992;
Goldberg, Scott, Davidson et al, 1992) report broadly similar results. Several
comprehensive reviews of studies comparing the psychosocial outcome of BCT with
mastectomy have thus concluded that although there may be some advantage to BCT
versus mastectomy for body image and sexual functioning, no substantial evidence of
better overall psychological adjustment for BCT has been demonstrated (Carlsson &
Hamrin 1994; Fallowfield & Clark, 1991; Hall & Fallowfield, 1989; Kiebert, de Haes, van
de Velde, 1991; Schain & Fetting, 1992).
A recent, well-designed meta-analysis of investigations reported between 1981 and
1995 was carried out by Moyer (1997). Effect sizes (ES) were calculated for different
categories of psychosocial outcomes reported in the literature and weighted by sample
size. Factors related to study design which may have influenced ES were examined,
including method of assignment to treatment (randomised versus non-randomised), and
length of time since surgery (less than 12 months versus 12 months or more). Mean
weighted ES for measures of psychological adjustment, marital-sexual adjustment, and
cancer related fears and concerns were small (0.2), with only body/self-image
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demonstrating a medium (0.4) ES (Cohen, 1988). Advantages for BCT were increased
for patients assessed more than one year post-operatively, and for patients who were
not randomised to treatment. Better psychological outcomes for BCT more than one
year after surgery may be due to psychological distress associated with adjuvant
treatment during the first year. Post-operative distress also may be compounded by
secondary problems such as pain, loss of sensation, stiffness, and swelling in the arm
of the operated side, even following breast conserving surgery (Maunsell, Brisson &
Deschenes, 1993). Women treated with different types of surgery may experience
distress for different reasons. Fallowfield et al (1986) report in one study, for instance,
that lumpectomy patients were concerned by feelings of fatigue and their slow recovery
after a small operation, whereas mastectomy patients who did not expect a swift
recovery found that treatment was less difficult than anticipated. Different procedures
may be related to different levels of specific feelings, for example, cancer itself may be
associated with anxiety, whereas breast loss or disfigurement may be associated with
depression (Deadman, Dewey, Owens et al, 1989). Similar to the conclusions of
previous reviewers, Moyer (1997) observes that 'unexpectedly, many of the findings
have been equivocal and typically show a lack of substantial benefits for breast-
conserving surgery as compared with mastectomy'. To the extent that even small effect
sizes may be clinically significant, however, demonstration of an advantage for BCT on
quality of life is considered important (Moyer, 1997).
Studies Comparing BCT with Mastectomy plus Reconstruction
Relatively few investigations have compared women treated with mastectomy plus
reconstruction to women treated with breast-conserving surgery. In one study, body-
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image and satisfaction with surgery was superior in the breast-conserving surgery
group, but no difference was found in sexual adjustment or fear of cancer recurrence
(Noguchi, Kitawaga, Kinoshita et al 1993). In a second study, no difference was found
between groups in body image, psychosocial adjustment to illness, and satisfaction with
sexual relationships (Schover, Yetman, Tuason et al, 1995). Schain, d'Angelo, Dunn et
al (1994) compared psychological outcome for women randomised to BCT versus
mastectomy with or without reconstruction. They reported better outcomes for patients
assigned to BCT, with no benefit of having reconstruction to the mastectomy group.
Another study which compared psychosocial outcome of BC with mastectomy and
reconstruction (Schover, Yetman, Tauson et al 1995) concluded that choice of local
treatment had little impact on psychosexual function or psychological distress, whereas
adjuvant chemotherapy was associated with longer term impairments in quality of life.
A recent study reported by Nissen, Swensen, Ritz et al (2001) compared outcome in
relation to quality of life for a total of 198 women who underwent one of three surgical
procedures: breast-conserving surgery; mastectomy alone; and mastectomy with
reconstruction. Baseline quality of life questionnaires were completed pre-operatively.
Questionnaires were completed again at 1, 3, 6, 12, and 18 months post surgery. The
results demonstrated that other than body image, aspects of quality of life were no
better amongst women who had undergone breast-conserving procedures or
mastectomy with reconstruction than for those who had undergone mastectomy alone.
Women who had undergone mastectomy with reconstruction in fact showed evidence
of greater distress at 18 months. This study highlighted several important points with
regard to factors other than type of surgery that are likely to have had significant effects
on women's adjustment and quality of life. Women in the mastectomy with
reconstruction group, for example, were likely to be younger, require more extensive
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surgery with a longer surgical recovery period than the BC group, and be recommended
subsequent treatment with chemotherapy. Women who received BC were also likely to
have significantly smaller tumours than either of the mastectomy groups.
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Table 1.5
Summary of Studies Comparing Psychosocial Outcome of Breast-Conserving Therapy
versus Mastectomy
Authors/ Journal Sample Design Timescale Outcome
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Stanton, 76 surgery; 3 from BC group
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Cancer. mths post- + RC groups
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(BC= Breast-conserving surgery; Mx = Mastectomy; RC= Breast Reconstruction; RT =
Radiotherapy; CT = Chemotherapy; HT = Hormone therapy; QOL = Quality of Life)
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1.6 Psychological Distress and Adjuvant Therapies
Treatment of disease involving adjuvant treatments such as radiotherapy,
chemotherapy or hormone therapy often has a major impact on perceived body image
and sexuality, as well as having implications for fertility in younger patients (Irvine,
Brown, Crooks et al, 1991) and present considerable physical and psychosocial
challenges (Moyer & Salovey, 1997).
Radiotherapy
During the first year post-surgery, adjuvant radiation that more often accompanies
breast-conserving procedures or the combination of surgery and radiation, may be a
source of psychological distress (Levy, Haynes, Herberman et al 1992; Steinberg,
Julian & Wise, 1985). Longer-term assessments may therefore be more sensitive to
potential advantages for breast-conserving surgery. This may explain why no
substantial benefits have been found for BCT versus mastectomy. Radiation therapy
usually follows a rigid schedule of treatment for several weeks. Most women do not
experience serious side effects, but itching, swelling, skin changes, and especially
fatigue may result (Seltzer, 1987). Difficulties with this treatment are reported to include
fear of radiation exposure and indelible marks on the body to indicate where to focus
radiation (Greenberg, 1988).
Chemotherapy and Hormone Therapy
The symptoms resulting from chemotherapy and hormone therapy can lead to
depression, low self esteem, disruption to family function, sexual inhibitions or loss of
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interest in sex, and fear of losing a partner (Myerowitz, Sparks & Spears, 1979; Seltzer,
1987).
Chemotherapy
Chemotherapy uses cytotoxic drugs to destroy cancerous cells throughout the body.
Chemotherapy is often administered over a period of six months to a year, and can
make patients physically ill in the days after each treatment (Hughson, Cooper, McArdle
& Smith, 1986). There are many chemotherapy agents available. Combination
chemotherapy has been shown to be the most effective as adjuvant therapy, and is
typically administered in six cycles over a six month period. Benefits of chemotherapy
appear to be higher for premenopausal than postmenopausal women. Anticipatory
anxiety is problematic for some women especially before the first chemotherapy
treatment (Jacobsen, Bovbjerg & Redd, 1993). Symptoms that can occur during
treatment include chronic fatigue, hair loss, weight fluctuation, infections, mouth sores,
altered taste sensations, anticipatory nausea and vomiting (Carey & Burish, 1988;
Nerenz, Leventhal, Love & Ringler, 1984). Kiebert, Hanneke, de Haes et al (1990)
studied the effect of chemotherapy on perceived quality of life in two groups of women
with early stage breast cancer, one of which received peri-operative chemotherapy.
Women were interviewed at 2 and 12 months post-surgery. At two months, the group
who had received chemotherapy reported reduced quality of life due to side effects of
fatigue and hair loss. No differences were found at 12 months. For younger women
chemotherapy may have implications for fertility, and longer term emotional
consequences of adjuvant treatment may therefore result from the risk of becoming
permanently sterile or at the very least having to wait several years before becoming
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pregnant because of the threat of cancer recurrence and risk of birth defects
(Greenberg, 1988).
Depression and Acceptance of Adjuvant Treatment
Detection of depression amongst breast cancer patients may be particularly important,
since depression in this population has been associated with a tendency to be less
proactive in obtaining healthcare (Watson, Haviland, Greer, Davidson & Bliss, 1999).
Depression is also suggested to be associated with reduced acceptance of adjuvant
chemotherapy following surgery. Colleoni, Mandala, Peruzzotti, Robertson, Bredart &
Goldhirsch (2000) report findings of a study comparing acceptance of adjuvant cytotoxic
drugs in 39 breast cancer patients who were identified as needing psychological
support and who met the DSM-IV criteria for depression, with a control group of non-
depressed patients (A/ = 78) matched for age and on tumour prognostic status (primary
tumour size, number of involved lymph nodes, oestrogen and progesterone receptor
status, histological grade) and treatment details (type of surgery). Only 51% of the
depressed group accepted adjuvant treatment, compared with 92% of the control
group. Psychological support and treatment for depression thus may increase
acceptance of chemotherapy, therefore improve prognosis for these patients.
Palliative Chemotherapy in Advanced Disease
In advanced disease, palliative chemotherapy may be administered. The major side
effects of such treatment are fatigue, gastrointestinal symptoms and pain (Payne,
1992). Quality of life for patients undergoing palliative chemotherapy appears to be
enhanced by administration at home rather than in hospital (Payne, 1992).
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Hormone therapy
Hormonal therapy, which affects secretions of endocrine glands, may be prescribed for
tumours influenced by hormones (Goodman, 1991; Rubenstein & Cirillo, 1985). Due to
hormonal suppression of oestrogen, hot flushes, amenorrhoea, and reduced vaginal
lubrication may result. Tamoxifen is the most widely used hormonal treatment for breast
cancer. Tamoxifen is a synthetic partial oestrogen agonist which acts primarily by
binding to the oestrogen receptor. Tamoxifen appears to produce benefits in pre and
post menopausal women, but these benefits are higher in post menopausal women.
The optimal duration of tamoxifen in women over 50 has been shown to be 5 years
(Early Breast Trialists Collaborative Group, 1992). The production of oestrogen requires
the presence and activity of the aromatase enzyme. Aromatase inhibiters have found to
be effective in treating breast cancer which no longer responds to Tamoxifen, and
shows survival advantages over progestogens which are currently the second line
hormonal agents (Dixon & Sainsbury, 1998).
Neoadjuvant Treatment
Primary medical therapy is increasingly being used for larger operable breast cancers.
Tumours will usually show either a useful response or progression within 12 weeks of
primary medical treatment. Induction (neoadjuvant) chemotherapy has been shown to
shrink large T2 and T3 tumours thus permitting quadrantectomy rather than
mastectomy, with post-operative consolidation therapy usually given (Dixon &
Sainsbury, 1998). Tamoxifen has been used as an adjuvant and as therapy for
metastatic breast cancer in premenopausal women. Recent trials have investigated the
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primary therapy using the new aromastase inhibitors (anastrozole, letrozole, and
vorozole).
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1.7 Individual Patient Factors Influencing Psychosocial
Outcome
Burton & Watson (1998) identify several key characteristics of patients at risk of
psychological problems (Table 1.6).
Table 1.6: Patients at risk of psychological problems (Burton & Watson, 1998)
• Previous psychiatric history
• Lack of support from family and friends
• Inability to accept the physical changes associated with the disease and its
treatment
• Lack of involvement in satisfying activities
• Prior adverse experience of cancer in the family
• Low expectations regarding the effectiveness of treatment
• Pre-existing marital problems
• Younger age at diagnosis
Age at Diagnosis
Age is believed to have an important influence on women's reactions to breast cancer
(Rowland & Holland, 1989; Derogatis, 1980). Younger women are more distressed than
older women by the impact on body image and sexuality, whereas older women may
react more to the threat to life, perhaps especially if they have experienced losses such
as the death of their partner (Holland & Rowland, 1989; Jamison,Wellisch & Pasnau,
1978). It cannot be assumed, however, that issues of body image are unimportant to
older women (Frank, Dunnington & Fitzgibbons, 1991). The developmental stage in
women's life at which breast cancer occurs may be relevant to the particular
challenges this presents. In a study of the issues facing women who are dealing with
breast cancer in their twenties, thirties, mid-life and later life, Oktay & Walter (1991)
illustrate how at different points, fertility, developing relationships, personal growth,
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career, children, ageing, maintaining a mature relationship, and dealing with multiple
losses are threatened and complicated by breast cancer. Age and developmental stage
are considered as factors that warrant further attention in breast cancer research in
relation to the amount and type of information required by patients, the optimal type of
surgical treatment, and the types of coping and support that are most beneficial (Moyer
& Salovey, 1997). Age may have an important influence on treatment choice, with older
women more likely to choose mastectomy and rating maintenance of attractiveness,
femininity and sexuality as less important in considering their treatment options than did
younger women (Satariano, Swanson & Moll, 1992; Stanton, Cameron, Danoff-Burg et
al, 2000). Older women also may be less strongly recommended BCT because
comorbidities can contra-indicate radiation (Satariano, Swanson & Moll, 1992). Younger
patients may be more likely to be offered breast-conserving procedures (Maunsell,
Brisson & Deschenes, 1989; Wellisch, Di Matteo, Silverstein et al, 1989). Older and
younger patients may have a different psychosocial response to surgical treatments,
and react more negatively to breast removal (Moyer, 1997). Younger breast cancer
patients may be more distressed generally (Holland & Rowland, 1989). Maunsell,
Brisson & Deschenes (1989) found that for women under 40 years old, breast-
conserving treatment was protective against psychological distress. Amongst women
aged 50-59 years old, breast-conserving treatment associated with more distress, and
in women aged over 70 years old there was no relationship between type of surgery
and level of distress. In at least one other study, women age 50-59 receiving breast-
conserving surgery have been reported to show less anxiety than those treated with
mastectomy (Maraste et al, 1992).
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Premorbid Adjustment
Stressful life events in the year before diagnosis and prior history of depression are
strong indicators for psychological distress after treatment for breast cancer (Maunsell,
Brisson & Deschenes, 1989). Psychological adjustment prior to diagnosis has also
been found to predict adjustment to the disease one year after surgery (Royak-Schaler,
1991).
Personality
The earliest observation of psychological aspects of cancer were documented by Galen
(200 A.D.), who noted that 'melancholic' women were at greater risk for depression than
'sanguine' women (Goldfarb, Driessen & Cole, 1967).Throughout the eighteenth and
nineteenth centuries, many observers commented on this relationship. Gendron (1701)
noted that anxious and depressed women were cancer prone, and Guy (1759)
suggested that women with hysteria and nervous difficulties, especially those of
'phlegmatic and melancholic' character were more likely to develop cancer. Walshe
(1846) implicated a state of 'defective innervation' (resulting from the stresses of a
difficult life) in cancer pathogenesis. In the 1960's theories of psychogenic origin for
cancer were proposed by several investigators. LeShan (1966) associated unresolved
loss, inability to express frustration and anger, and tenuous affective relationships with
cancer patients. Schmale & Iker (1964) similarly identified a pattern of separation and
loss, depression, and sense of helplessness-hopelessness with cancer. Based on his
research with lung cancer patients, Kissen (1966) observed a personality pattern in his
exclusively male patient sample that was associated with few outlets for emotional
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expression. The most complete psychological etiologic model for cancer at this time
was probably the theory of 'psychophysiological complimentarity' described by Bahnson
& Bahnson (1966). This concept associated the development of cancer with repressed
emotional conflicts related to loss. During the last two decades, the role of personality
and mental state and other psychosocial variables influencing induction of malignancy
and tumour progression has received increased empirical attention (Cooper & Watson,
1991). There are many methodological problems in examining the role of psychological
factors, including effects on psychological functioning of malignancy present prior to
diagnosis, and the impact of the diagnosis itself (Walker & Eremin, 1995). There does,
however, appear to be some evidence for a type C or 'cancer prone' personality. For
example, there is evidence that some cancer patients score highly on the L-scale of the
Eysenck Personality Inventory (originally designed to detect patients who are 'faking
good') and associated with suppression of certain feelings such as anger, passive
coping with stressful events, and a strong need to conform (Eysenck, 1994). In patients
with lymphoma, L-scores assessed immediately following diagnosis have been found to
be an independent prognostic factor for survival, as was depressed mood (Ratcliff,
Dawson & Walker, 1995).
Coping Styles
Morris, Greer & White (1977) identify 5 categories of response to diagnosis of breast
cancer. These are: denial; fighting spirit; stoic acceptance; anxious/depressed
acceptance; and helplessness/hopelessness. Greer, Morris, Pettingale & Haybittle
(1990) reports that fighting spirit and denial are better responses than stoic acceptance,
anxiousness or helplessness. Friedman et al (1990) report on a partial replication of a
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previous study of coping and adjustment to breast cancer. Coping styles were assessed
in 49 women. The results indicated that fighting spirit was related to better
psychological adjustment, and that coping by avoidance was related to poorer
adjustment. Denial as a coping strategy was unrelated to adjustment. Orr & Meyer
(1990) investigated minimising threat as a coping strategy in 49 breast cancer patients
compared with a comparison group of 57 healthy women. It was found that healthy
subjects were more negative about cancer outcome than breast cancer patients, who
appeared to reappraise the threat more positively after diagnosis and treatment. The
authors conclude that 'diminished threat appraisal' is therefore an effective coping
strategy for breast cancer patients. Similarly, Dunkell-Schetter, Feinstein, Taylor &
Falke, (1992) examined coping patterns amongst a sample of 603 cancer patients (78%
women and 22% men), of whom 42% had breast cancer. Five coping patterns were
identified: seeking or using social support; focusing on the positive; distancing; cognitive
escape-avoidance; and behavioural escape-avoidance. Studies of what patients can do
to successfully cope with diagnosis and treatment for breast cancer have, however, so
far failed to provide evidence of which coping strategies are particularly helpful (Irvine et
al, 1991). Recent findings suggest that emotionally expressive coping, which involves
actively processing and expressing emotions, may be a key predictor of psychological
and physical adjustment to breast cancer, and is related to enhanced perceived quality
of life (Stanton, Danoff-Burg, Cameron, et al 2000).
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1. 8 Issues of Treatment Decision Making and Choice
Advances in cancer medicine including development of new drug treatments means
that there are now an increasing range of treatment options available. Whilst these
advances bring many positive benefits, they present new challenges regarding
treatment decision making and choice. The majority of cancer patients want to have an
active and collaborative role in decision making and to have information regarding the
disease and its treatment (Blanchard, Labreque, Ruckdeschel & Blanchard, 1988;
Hack, Degner & Dyck, 1994). Doctors play an important role in women's decision
making, and variability in physicians opinions regarding appropriate treatments for
breast cancer has been documented (McFall, Warnecke, Kaluzny et al, 1994). The
need for studies addressing these important issues has been highlighted by several
influential researchers (e.g. Fallowfield, 1990; Holland & Rowland, 1990). Perhaps
surprisingly, relatively few studies (Ashcroft, Leinster & Slade, 1985; Kasper, 1995;
Margolis & Goodman, 1984; Morris & Ingham, 1988; Owens, Ashcroft, Leinster &
Slade, 1987; Siminoff & Fetting, 1991; Ward, Heidrich & Wolberg, 1989) have been
carried out investigating the process of women's treatment decision making on
adjustment. Those studies which have been reported have tended to use small samples
(e.g. N < 30), have used unsystematic clinical interviews to assess decision making, or
are based entirely on retrospective reports obtained from patients post-surgery. Only
one prospective, longitudinal study is known to have been carried out (Stanton,
Cameron, Danoff-Burg et al, 1998). The study monitored 76 women with breast cancer
from diagnosis through to one year and examined the influence of women's
expectations of treatment before surgery on treatment choice and subsequent
adjustment. Women's expected consequences of surgical options, assessed before a
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final decision making appointment with their physician, successfully predicted those
patients electing BCT versus mastectomy. The elected treatment itself made little
difference in presurgery and outcome perceptions or adjustment. An important
exception to this was that patients electing BCT rated their physicians agreement as
more important than did mastectomy patients before surgery. The authors suggest that
one reason for this may be that only those who believed that their surgeons strongly
support the BCT option may choose it. As this sample are likely to have seen the
evolution of less invasive surgery for breast cancer, it is suggested that they may seek
reassurance from their physician that it is no longer an experimental procedure. At one
year, BCT patients also rated avoiding additional treatment as more important, possibly
due to the longer initial treatment associated with this procedure. No group differences
were revealed with regard to perceptions of outcome in relation to appearance,
femininity, and sexuality. BCT patients in fact reported greater satisfaction with
treatment outcome on only a single item concerning the effect of treatment on
appearance. The finding that discrepancies between women's expectancy over actual
outcome of treatment were associated with more distress at 3 months and at one year
held up even controlling for age and presurgery adjustment. Several studies have been
reported where patients (or a proportion of the sample) have been given a choice of
treatment (e.g. Fallowfield, Hall, Maguire & Baum, 1990; Noguchi, Kitawaga, Kinoshita
et al 1993; Pozo, Carver, Noriega et al 1992; Steinberg, Juliano & Wise, 1985). These
studies suggest that offering patients choice of treatment and involvement in decision
making may improve psychological outcome irrespective of type of procedure chosen.
This control may be especially important in the context of a disease that often makes
patients feel a lost sense of control (Moyer, 1997). Although some investigators argue
that the majority of patients wish to be involved in the decision making process (e.g.
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Ward et al , 1989), others have suggested that decision making may be an additional
burden for patients during a time of already high anxiety, and may lead to patients
feeling responsible if treatment is unsuccessful (Morris & Ingham, 1988). In one study of
recently diagnosed breast cancer patients, it is reported that 52% of patients preferred
that their surgeon made the decision for them (Luker, Leinster, Owens et al - cited in
Fallowfield, Hall, Maguire et al, 1994).
In their study on treatment decision making amongst women offered a choice of breast
conserving treatment or mastectomy. Stanton, Cameron, Danoff-Burg et al (2000)
reported that in general women reported positive expectancies of their treatment, which
were maintained during treatment. At one year after diagnosis though, women were
less likely to beiieve that treatment would prevent recurrence than they were before
surgery. This occurred aespite none of the women actually experiencing recurrence,
highlighting the importance of such concerns in terms of quality of life for cancer
patients, as noted in earlier studies with patients who had undergone mastectomy
(Northouse. 1981). Expectances regarding positive outcome were different for the two
types of treatment (i.e. women choosing mastectomy did not believe that BCT would be
curative) rather than related to more generalised optimism in this sample. Although
dispositional optimism has beer, reported to be associated with lower distress in breast
cancer patients (Carver, Pozo, Harris et al 1993), the results of this study suggest that
discrepancies between expected and perceived outcomes rather than positive
expectancies by themselves that influence adjustment.
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1.9 Aims and Objectives of Current investigation
Aim: The aim of this study was to examine short-term psychological adjustment
amongst patienis undergoing breast cancer surgery.
Objectives:
1. To investigate the psychological impact of diagnosis in relation to evidence of
acute stress response, and to assess changes in this response between
diagnosis arid follow up one month after surgery.
2. To compare psychosocial outcome of surgery for patients who received breast-
conserving surgery versus mastectomy. Psychosocial outcome was assessed at
baseline and at follow up one month after surgery in terms of several key
indicators of psychological adjustment: levels of psychological distress
(anxiety/depression); coping response; and body image satisfaction.
3. To examine the relationship between control and expression of negative
emotion and other psychosocial outcome measures.
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1.10 Hypotheses
Hypothesis 1: It was hypothesised that psychological reactions to diagnosis of breast
cancer would be associated with an acute stress response, with levels of intrusive
distress and avoidance predicted to be higher amongst patients assessed soon after
diagnosis than at follow up one month post surgery.
Hypothesis 2: It was hypothesised that breast-conserving (BC) surgery versus
mastectomy would result in better short-term psychological adjustment, as indicated by
levels of psychological distress, coping response to diagnosis, and satisfaction with
body image at follow up one month after surgery.
Hypothesis 3: It was hypothesised that suppression of negative emotion amongst
patients diagnosed with breast cancer would predict poorer psychosocial outcome,
indicated by greater psychologicai distress, less adaptive coping responses, and





Short-term psychological adjustment was investigated in a longitudinal study of patients
with early stage breast cancer. Patients were assessed pre and post surgery using
psychological measures to assess evidence of acute stress response and adjustment
over time. Psychosocial outcome (levels of psychological distress, coping responses
and satisfaction with body image) were compared for patients who had undergone
breast-conserving surgery versus mastectomy.
Calculation of Statistical Power/Expected Effect Size
A minimum of 50 patients were calculated as being required for the study in order to
achieve sufficient statistical power to demonstrate moderate effects sizes (ES) at the
0.8 level (Cohen, 1988). Fewer numbers of participants were recruited than was
anticipated due to timescale constraints of this study.
Sample
The original sample comprised 29 patients newly diagnosed with early stage (operable)
breast cancer, assessed soon after diagnosis. Follow-up data were available for 25
patients. In two cases, patients subsequently entered a neoadjuvant treatment trial
(Impact Study), therefore the date of surgery was delayed. Two patients who were
contacted for follow up indicated that they wished to withdraw from the study, in both
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cases as their pathology results following surgery were worse than they had expected.
Information obtained from medical records on patient demographics (age, marital and
employment status), type of disease and treatment related variables for the remaining
25 patients who represented the study sample is shown in Table 3.1. The mean age of
patients was 58.13 years (S.D.= 11.37), with an age range from 38-85 years. Two-thirds
of the sample (A/= 16) received breast conserving (BC) surgery, involving wide local
excision (WLE) and axillary node sampling/clearance. Of the 9 patients who received a
mastectomy, only one patient is known to have opted for immediate reconstruction.
BC Mx Total
CLINIC:
QMH 9 5 14
WGH 7 4 11
TOTAL 16 9 25
PA TIENT DEMOGRAPHICS:
AGE
Mean 53.43 65.44 58.13
S.D. 10.43 8.93 11.37
(Range = 38-78 yrs)
MARITAL STATUS
Married 12 5 17
Other/not known 4 4 8
EMPLOYED 11 2 13
BC Mx Total
SCREEN DETECTED:
YES 71 5 11
DISEASE TYPE:
DCIS 3 0 3
INV-NST 9 8 17
INV-LOB 1 1 2
INV-TUB 3 0 3
ADJUVANT THERAPY:
RT 16 2 18
CT 5 1 6
HT 13 6 19




Ethical approval was obtained prior to the study commencing. Approval was sought
from Fife Health Board Ethics Committee in October 2000, which was granted in
November 2000. Recruitment of Fife patients began at the end of January 2001. Due to
fewer numbers of participants being recruited than was originally anticipated,
permission was sought to extend the study to Lothian Health Board in April 2001.
Recruitment of Lothian patients began in May 2001
Patient Recruitment
Patients were recruited from a consecutive sample of patients attending two Specialist
Breast Care Units - (1) Queen Margaret Hospital (QMH), Dunfermline, (2) Western
General Hospital (WGH), Edinburgh. These units have close medical links through the
Consultant Breast Surgeons and the clinical team, and post-operative radiotherapy is
provided for patients from the QMH at the WGH. Patients were recruited for the study
shortly after undergoing investigation for breast cancer and having a diagnosis
confirmed. In almost all cases diagnosis was confirmed by triple assessment (clinical
examination, mammography and fine needle aspiration (FNA) cytology). Patients at
QMH receive their diagnosis the same day as their first appointment ('one-stop'
assessment). At the WGH, patients receive their diagnosis at their second appointment.
Patients were introduced to the study by their Specialist Breast Care Nurses. An
information sheet about the study (see Appendix 1) was given to patients during their
clinic appointment at which diagnosis was confirmed. Patients were then asked whether
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or not they wished to take part in the study when they returned to the clinic the following
week for their final staging appointment.
Study Inclusion/Exclusion Criteria
Patients were identified for study inclusion by the Specialist Breast Care Nurses at each
unit. All patients with newly diagnosed, early stage (operable) breast cancer were
considered for study inclusion. There was no upper age limit on study inclusion.
Patients with known evidence of neurological impairment/dementia, or serious mental
illness were excluded from the study.
Patient Consent
Written, informed consent was obtained prior to patients entering the study. Patients
were advised that their decision whether or not to participate in the research would not
affect their treatment in any way, and that they were free to withdraw from the study at
any time. Patients were given 5 days to consider whether they wished to take part in the
study after receiving the patient information sheet (see appendix).
Protocol
Assessment interviews lasted approximately 45 minutes. Patients were given the
opportunity to have their relatives or a friend present during interviews.
Pre-surgery: Patients were interviewed at the breast unit within one week of diagnosis.
Patients were seen on the same day as attending their clinic appointment during which
finai staging results were discussed and they were given a date for surgery.
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Post-surgery: Follow-up appointments were arranged within the first month after
patients had received the results of their surgery from the clinic (results of surgery were
available within 10 days to two weeks of the operation). Follow up was planned for
within this timescale to try to avoid possible confounding of results with effects of
adjuvant therapy. As patients were not usually due to return to the clinic within this time
period, follow up appointments were arranged to take place at the patients home. Follow
up appointments were carried out throughout Fife and Lothian regions.
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2.3 Psychological Measures
Copies of all measures used are included in Appendix 2.
Anxiety and Depression ; HAD
The Hospital Anxiety and Depression Scale (HAD, Zigmond & Snaith, 1983) is a brief,
14-item scale measuring anxiety and depression. The HAD is a well-validated clinical
research scale, designed for use in out-patient medical settings which does not include
items that may be confused with physical symptoms related to illness. Anxiety and
depression are measured on two separate subscales, with each item scored from 0 to
3, so that the total scores for each subscale range from 0 to 21. The cut-off score for
clinical 'caseness' for anxiety or depression is a subscale score of more than 11. Mean
anxiety and depression subscaie scores have been reported for a clinical population of
573 patients with cancer at the time of initial diagnosis or first recurrence (Moorey,
Greer, Watson et al 1991).
Acute Stress Response; IES
The Revised Impact of Events Scale (lES, Horowitz, 1979) is designed to measure
symptoms associated with traumatic stress response, and is widely reported in the
literature on traumatic stress. The IES is a 15 item questionnaire that provides two
subscale scores for intrusive distress ('I thought about it when I didn't mean to',
'Pictures about it popped into my mind', ' Any reminder brought back feelings about it')
and symptoms of avoidance/emotional numbing ('I tried not to talk about it', 'My feelings
about it were kind of numb'), items are scored on a 4 point scale based on the
frequency with which patients rate each statement as being true for them during the
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past 7 days (0 = not at all, 1= rarely, 3 = sometimes, 5 = often). For the purpose of this
study, patients were instead asked to rate how often each statement was true for them
since their diagnosis (pre-surgery assessment), and since their operation (post-surgery
assessment). Satisfactory reliability is reported for the IES by Horowitz (1979) based on
a sample of 66 patients who had experienced traumatic events including bereavement
and serious personal injury. Mean scores on the IES subscales for this sample were
reported for intrusion (mean = 21.4, S.D. 9.6) and for avoidance (mean = 18.2, S.D. =
10.8). Reliability of the IES has since been confirmed in subsequent studies, and its
validity demonstrated for use with a range of clinical populations (Turner & Lee, 1998).
Scores on the IES have been found to be highly correlated with traumatic stress
responses as assessed by formal interview based on DSM criteria. The IES has been
used to assess acute stress response in one other study of breast cancer patients
(Tjemsland, Soriede & Malt, 1996). IES scores were reported in this study for patients
who were assessed pre- surgery (intrusion: mean = 17.2, S.D = 9.0; avoidance mean =
15.0, S.D. = 8.5) and 6 weeks post-surgery (intrusion: mean = 15.0, S.D. = 8.5;
avoidance = 10.1, S.D. = 7.5).
Coping responses: MAC
The Mental Adjustment to Cancer Scale (MAC, Watson et al 1988) is a 40-item scale
designed to assess adjustment or response to cancer diagnosis. It is used as a
measure of the coping styles adopted by cancer patients.
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The MAC incorporates 5 subscales:
• Fighting spirit (FS)
• Helplessness/hopelessness (HH)
• Anxious preoccupation (AP)
• Fatalistic (FA)
• Avoidance (AV)
The scale was developed based on earlier work (Greer et al 1979; Morris et al 1985;
1992; Pettingale et al 1985) using clinical interviews which reported that coping styles of
fighting spirit and denial tend to be associated with better outcomes in terms of
psychological morbidity, and possibly overall survival and recurrence-free survival
(although these findings are more tentative). Reliability and validity data for the MAC is
reported based on a study of 235 patients with various stages and types of cancer
(Watson et al, 1988). Acceptable internal reliability is reported. High levels of internal
validity were reported for correlations between respondents self-ratings and ratings by
their partners. Highly significant correlations are reported between anxious
preoccupation and HADS anxiety, and between HADS depression and
hopelessness/helplessness and fatalistic responses. Raw scores on each of the 5
subscales are converted to T-scores providing a coping-styles profile for three
subscales: 'fighting spirit' versus 'hopelessness' (FSH), 'anxious preoccupation' (AP)
and 'fatalistic' (FA). The avoidance subscale, which contains just one item ('I don't really
believe I had cancer') is not included in this profile. Mean T-scores of 50 are reported
for responses on each of these three scales based on the Watson et al (1998) sample.
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Body Image Satisfaction: BIS
Body image was examined using the 10-item Body Image Scale (BIS; Hopwood,
Fletcher, Lee & Ghazal, 2001) designed to assess body image as a psychosocial
outcome measure in clinical treatment trials. The Body Image Scale (BIS) was used to
provide a measure of body image satisfaction at baseline (pre-surgery) and to assess
any changes as a result of treatment. Responses to each item on the scale are rated on
a 4 point Likert scale (0 = not at all, 1 = a little, 2 = quite a bit, 3= very much). The BIS
was designed for use with any cancer patient group likely to experience body image
concerns as a result of their disease or its treatment. The BIS has been validated on a
sample of 276 cancer patients, that included a subsample of 160 breast cancer
patients. Reliability and validity data are reported for this measure by Hopwood,
Fletcher, Lee & Ghazal (2001).
Suppression of Negative Emotion: BES
An adapted, short-version of the Basic Emotion Scale (BES, Power, 2001) was
administered. This scale assesses a number of core emotions, providing both state
(how often have you experienced these feelings during the last 7 days?) and trait (how
often do you usually experience these emotions?) responses. Patients are also asked
to rate their perceived control of emotions that they experience. The BES is a recently




Statistical Analysis of Results
Data were analysed using SPSS for windows, PC version, release 10.0. Data obtained
for continuous variables were normally distributed. Statistical tests used to examine
each of the hypotheses are described below. Statistical significance was accepted at
the 0.05 level.
Testing of Hypotheses 1 and 2
To test hypotheses 1 and 2, a mixed within and between subjects repeated measures
ANOVA was used. The main effect examined for within subjects comparisons was time
of assessment (pre or post surgery). The interaction of type of surgery - breast
conserving (BC) surgery versus mastectomy (Mx) - with time of assessment was
examined.
3.1 Hypothesis 1
Hypothesis 1: It was hypothesised that psychological reactions to diagnosis of
breast cancer would be associated with an acute stress response, with levels of
intrusive distress and avoidance predicted to be higher amongst patients assessed
soon after diagnosis than at follow up one month post surgery.
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Evidence of Acute Stress Response
One quarter of the sample (N-7) assessed soon after diagnosis scored highly (IES
subscale scores >19) for intrusive distress and avoidance. At follow up one month after
surgery, four patients (17% of sample) scored highly on intrusion and avoidance. Mean
scores obtained on IES measures of intrusion and avoidance before and after surgery,
and results of the repeated measures ANOVA are presented in Tables 3.1 to 3.3.
Significantly higher scores were found pre-surgery for total IES total scores (F(1,23) =
13.375, p < 0.05), and on scores for intrusive distress (F(1,23) = 9.452, p < 0.05) and
avoidance (F(1,23) = 8.091, p < 0.05). No significant differences were found for the
interaction of type of surgery and time assessed on IES total or intrusion/avoidance
subscale scores.



























































































Hypothesis 2: It was hypothesised that breast-conserving (BC) surgery versus
mastectomy would result in better short-term psychological adjustment, as indicated by
levels of psychological distress, coping response to diagnosis, and satisfaction with
body image at follow up one month after surgery.
Psychosocial Outcome of BC Surgery versus Mastectomy
(i) Anxiety and Depression
Amongst women assessed shortly after diagnosis, clinically significant levels of distress
(HAD scores >11) were found for anxiety in eight cases (one third of sample) and for
depression in just one case (< 5% of sample). None of the patients assessed at follow
up one month after surgery achieved clinically significant scores on HAD subscales for
anxiety or depression. Mean scores obtained on HAD measures of anxiety and
depression before and after surgery, and results of the repeated measures ANOVA are
shown in Tables 3.4 to 3.6. Significantly higher HAD total scores were found for
assessment pre versus post surgery (F(1,23) = 19.442, p < 0.05). HAD subscale scores
were significantly higher before surgery for anxiety (F(1,23) = 47.384, p < 0.05), but not
for depression. No significant differences were found for the interaction of type of
surgery and time assessed on anxiety or depression.
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Mean scores for coping responses assessed using the MAC (FSH = Fighting Spirit
versus Hopelessness; AP = Anxious Preoccupation; FA =Fatalistic) and results of the
repeated measures ANOVA are presented in Tables 3.7 to 3.9. Patients scores for
fatalistic coping responses were higher soon after diagnosis than at follow up after
surgery (F(1,23) = 7.387, p < 0.05). No significant differences were found between
scores on AP or FSH coping responses assessed before and after surgery. There were













F(df=1,23) SIG (*p<0.05) F(df=1,23) SIG (*p<0.05)
BC PRE 50.63 (8.16)
(N=18) POST 50.94






SAMPLE PRE 51.08 (9.05)
(N=25) POST 50.40
(10.65)

































































Table 3.9: Mean MAC FA scores pre/post surgery and results of repeated measures
ANOVA
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(iii) Body Image Satisfaction
Mean Body Image Scale (BIS) scores obtained pre and post surgery, and results of the
repeated measures ANOVA are reported in Table 3.10. Patients in both groups rated
their level of dissatisfaction with body image significantly higher post surgery (F(1,23) =
6.98, p < 0.05), with no effect found for type of surgery (BC v Mx).


























Table 3.10: Mean BIS scores pre/post surgery and results of repeated measures ANOVA
Influence of other factors on adjustment
Age and Screening
Patients who received breast conserving surgery were significantly younger than those
who underwent mastectomy, with a mean age difference of 12.02 years (t= 2.845,
df=23, p<0.05). Patient age was entered as a covariate within the repeated measures
design. Whether or not cancer was screen detected was entered as another factor,
since patients identified through screening were those with DCIS. Data were re-
analysed for scores obtained on each of the measures pre and post surgery for both
surgical groups. Significant covariate effects were found between groups for age on
HAD anxiety subscale scores (F (1,23) = 4.488, p< 0.05), IES total scores (F (1,23) =
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5.305, p <0.05) and IES intrusion scores (F (1,23) = 4.868, p <0.05). No significant
covariate effects were found for screening on any of the psychological measures.
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3 3 Hypothesis 3
Hypothesis 3: It was hypothesised that suppression of negative emotion amongst
patients diagnosed with breast cancer would predict poorer psychosocial outcome,
indicated by greater psychological distress, less adaptive coping responses, and
greater dissatisfaction with body image.
Influence of Emotional Suppression on Adjustment
Backward multiple linear regression analyses were performed to investigate whether
expression of negative emotion and negative emotional control predicted outcome in
terms of measures of psychological adjustment. Results of the analyses demonstrated
that significant contributions were made by expression of negative emotion (state) and
negative emotional control assessed soon after diagnosis using the BES, to the
determination of IES total scores (F2,22 = 6.24, p <0.05, R2 =.36) as well as IES
subscale scores for intrusive distress (F2,22 = 4.66, p <0.05, R2 =.29) and avoidance
(F2,22 = 5.24, p <0.05, R2 =.32). Backward linear regression analysis on levels of body
image satisfaction post-surgery (assessed using the BIS) further demonstrated a
significant contribution of negative emotional control to scores obtained on this measure
(F2,22 = 7.74, p <0.05, R2 =.25). Due to the small sample, findings must be interpreted
with caution, but suggest that higher levels of negative emotion together with greater
attempt to control, or suppress negative emotion in response to diagnosis is predictive
of symptoms of acute stress response (intrusion and avoidance), and greater
dissatisfaction with the outcome of treatment in terms of body image one month after
surgery. As the questionnaires used to measure these concepts have not yet been




Short-term psychological adjustment was investigated in a longitudinal study of patients
with early stage (operable) breast cancer. Twenty-nine patients completed baseline
psychological measures. Follow up data one month after surgery was available for 25
patients. The study attempted to address a number of specific research questions
relating to the psychological impact of diagnosis, and the effects of surgery on aspects
of psychological adjustment, namely: (1) 'Is diagnosis of breast cancer associated with
evidence of an acute stress response?' (2) 'Is psychosocial outcome at one month after
surgery better for patients who have undergone breast-conserving surgery versus
mastectomy?', and (3) 'Are emotional control and suppression of negative emotion
associated with poorer psychological adjustment?' Results of the study are reported in
this section, and findings compared with those previously reported in the literature.
Methodological limitations of the present study are highlighted. Implications of the
results for psychosocial care of breast cancer patients are discussed. Finally,
conclusions are drawn and directions for future research identified.
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4.1 Summary of Main Findings
Evidence of Acute Stress Response
Previous studies have suggested that diagnosis of cancer (Andrykowski, Griener,
Altmaier et al, 1995; Lepore & Helgeson, 1998; Tjemsland et al 1996) or recurrence
(Cella, Mahon & Donovan, 1990) may be associated with acute stress reactions. Such
responses are characterised by alternation between intrusive distress (thoughts or
images about cancer or its treatment) and behavioural avoidance (avoidance of
reminders, numbing of emotional response). Diagnosis of breast cancer was associated
with an acute stress response for 28% of patients in this sample (A/=7) who scored
above clinical caseness levels for intrusion and avoidance on the IES soon after
diagnosis. This level is slightly lower than that reported in Tjemsland et al's (1996) study
of 106 breast cancer patients, among whom acute stress response in described in one-
third of the sample. At follow up one month after their operation, levels of intrusive
distress and avoidance were significantly lower (p <0.05) compared with levels
assessed shortly after diagnosis for patients in this sample. However, in a proportion of
cases (A/= 4), patients continued to score above the level for clinical significance for
intrusion and avoidance, representing 17% of the sample. It is possible that these
patients may be at higher risk for poorer adjustment, since assessment of distress at 4-
6 weeks after exposure to a stressor has been found to predict reliably subsequent
adjustment problems in the trauma literature (Budin, 1998). This level is higher than
previously reported by Tjemsland et al (1996), who report that at follow up 6 weeks post
surgery only 8% of patients in their sample continued to experience clinically significant
levels of traumatic distress. Differences in levels of intrusive distress and avoidance at
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follow up may be a factor of variations between studies in the stage of treatment at
which patients were re-assessed. In the Tjemsland et al (1996) study, for example,
almost all patients allocated to adjuvant therapies had commenced treatment by follow
up. For patients in this sample, intrusive thoughts at follow up post surgery were related
to apprehension regarding starting radiotherapy or chemotherapy especially. Monitoring
of stress response in breast cancer patients is of potential clinical importance, since
patients who demonstrate high levels of traumatic stress may need help in coping with
the situation in order to moderate distress and to improve their coping with normal daily
life (Cordova et al, 1995). Further follow up of a larger sample of patients during
treatment is therefore required to assess changes in levels of traumatic distress over
time.
Psychosocial Outcome of BC Surgery versus Mastectomy
Psychosocial outcome of breast conserving (BC) surgery versus mastectomy (Mx) was
examined by comparing baseline measures of psychological distress, stress response,
adjustment and coping, and body image satisfaction with those obtained at one month
after patients' operations. No significant differences were found between patients in
each of the surgical groups on any of the measures used. These findings are broadly
consistent with the results of several recent studies using much larger samples (e.g.
Stanton et al, 2000; Nissen, 2001), and with the results of a well-designed meta¬
analysis of over 40 studies in this field, that have assessed patients at various times
since diagnosis (Moyer, 1997). The exception to this was the lack of observed effect for
differences in body image between groups, discussed below.
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Body image
In this sample, no difference was found between patients who had undergone either
breast conserving surgery or mastectomy in relation to body image. Patients in both
groups, however, were less satisfied with body image after surgery. Relatively few
previous studies have included baseline measures of body image satisfaction. Of the
results of over 40 studies now published comparing psychosocial outcome of BC with
mastectomy (see Table 1.5 in introduction), pre-surgery measures of body image
satisfaction were included in just six studies. Results of earlier studies, using relatively
small samples of up to 51 patients (e.g. Ashcroft et al, 1985; Wellisch et al, 1989) report
better body image satisfaction in BC versus mastectomy patients assessed a few
months to one to three years post surgery. Length of time assessed after surgery has
been suggested as an important factor (Moyer & Salovey, 1997), as it is assumed that
body image issues may become more important to patients at the end of treatment,
since during treatment more immediate concerns associated with diagnosis of life-
threatening illness and managing the effects of treatment may be a priority. Subsequent
studies (e.g. Goldberg et al, 1992; Lee et al, 1992) in which baseline measures of body
image satisfaction were completed using much larger samples (> 100 patients) failed to
replicate this effect. More recent prospective studies (Stanton et al, 2000; Nissen et al,
2001), using samples of 186 and 198 patients respectively, have highlighted the
complexity of issues surrounding evaluation of body image satisfaction and other
aspects of psychosocial outcome after treatment. For example, patients who are given
a choice of treatment appear to do better psychologically irrespective of the type of
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treatment chosen (Fallowfield et al, 1990). Choice of treatment is not possible for all
patients, however. In the Nissen et al (2001) study, women who underwent mastectomy
with reconstruction (N = 40) were likely to be younger, require more extensive surgery,
and be more likely to receive adjuvant cytotoxic drug treatment than women who
received breast conserving surgery (A/=103). Mastectomy may be recommended in
cases where the cosmetic outcome of breast-conserving surgery will be unsatisfactory,
or where the tumour is large compared to the size of the woman's breast (Dixon &
Sainsbury, 1998). For patients who are given a choice of treatment, decisions regarding
whether or not to elect breast conserving treatments rather than mastectomy may be
influenced by the need for adjuvant radiotherapy, which more often accompanies breast
conserving treatments. Several reports have suggested that for some women,
mastectomy may be preferred, essentially to get the treatment over with, or as women
may believe that the mastectomy is more likely to get rid of the cancer (Fallowfield &
Clark, 1992). Many of the women seen in this study expressed having sought
reassurance from their doctors that the cancer had been 'removed' by their operation.
Cancer related fears and concerns
Receiving a diagnosis of breast cancer it thought to be the primary cause of distress,
which may supercede more cosmetic concerns regarding appearance after surgery
(Fallowfield & Clark, 1992). For patients included in this sample, significantly greater
levels of psychological distress (anxiety and depression), and traumatic stress were
found at baseline assessment soon after diagnosis than at follow up one month after
surgery (p<0.05). For example, clinically significant levels of psychological distress were
present in one third of the sample assessed soon after diagnosis By follow up one
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month after surgery, none of the patients in this sample scored above clinical
'caseness' for anxiety or depression on the HAD scale, suggesting that it was receiving
a diagnosis of breast cancer itself rather than the effects of surgery that were
associated with greatest distress in this sample. Assessments of cancer patients made
at time of diagnosis show higher morbidity rates than those made 3 to 12 months after
diagnosis, suggesting that these tend to be transient reactions which have usually
remitted by the end treatment (Derogatis, Morrow, Fetting et al 1983). Identifying those
patients who experience substantial levels of psychological distress during treatment
and beyond is important in order that appropriate support can be provided or specialist
referral made where necessary.
Coping and Adjustment
Coping responses to cancer diagnosis were similar for patients assessed pre and post
surgery. Response profiles for each of the coping strategies assessed were similar, with
patients in this sample scoring in the average range compared with scores obtained for
other groups of cancer patients (Watson et al, 1988) on MAC subscales assessing
fighting spirit (' I try to keep a very positive attitude', 'I have plans for the future', 'I think
of other people who are worse off ) versus hopelessness ('I feel like giving up');
anxious preoccupation ('I worry about the cancer returning or getting worse'); and
fatalistic attitudes ('I've put myself in the hands of God', 'I feel that I can't control what is
happening'). There was no difference between surgical groups in the type of coping
responses used by women in this sample. Patients in this sample appeared to have
mobilised a range of coping responses soon after diagnosis. Levels of fighting spirit,
which has been associated with good psychological adjustment in women with breast
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cancer (Friedman et al, 1990), were no different at baseline than when patients were re¬
assessed one month after their operation. Anxious preoccupation was also more
common before surgery than after, with the only difference in coping responses before
and after surgery observed for items indicating fatalistic attitudes, which were more
frequently endorsed in patients assessed soon after diagnosis (p< 0.05). Patients'
responses at both of these times would appear to be adaptive, since levels of distress
had decreased by assessment one month after surgery. It is possible that the similar
coping response profile for patients assessed pre and post surgery may reflect the
relatively short time period involved between diagnosis and follow up in which
processing of the experience was able to occur. Long term follow up of the sample
might therefore have resulted in changes in coping responses used at various times
during treatment. Alternatively, patients who have mobilised effective coping strategies
in response to diagnosis may have been more likely to have agreed to participate in this
kind of research study, possibly reflecting sample bias.
Influence of Other Factors on Psychosocial Outcome
Age
Age has been identified as one factor that may be related to psychosocial outcome of
breast cancer surgery. Younger women are thought to show evidence of greater
psychological distress in relation to diagnosis, and to express more concern regarding
the effect of treatment, including surgery, on body image and sexuality than older
women (Moyer & Salovey, 1997). The findings of this study confirm that patients who
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are younger and who receive more extensive surgery show greater levels of overall
psychological distress and intrusive distress (p <0.05).
Screen Detected Cancer
It has been suggested (Farmer, Payne & Royle, 1995) that patients with screen
detected cancers may experience less psychological distress, since these cancers may
usually be detected earlier and a model of early disease and favourable outcome may
be presented. Perhaps surprisingly, patients who had screen detected cancers in this
sample (A/=12) were not found to experience any less distress than women who had
presented symptomatically. Again, this may have been a feature of small sample size.
Alternatively, it may be that there were few differences between women with screen
detected cancer and those who had presented with breast lumps in this sample.
Relationship Between Emotional Suppression and Adjustment
It was predicted that higher control of negative emotions such as anger, fear, sadness
and guilt would be associated with poorer adjustment to cancer diagnosis. In this
sample, higher scores for expression of negative emotions (state) and for emotional
control (suppression) assessed soon after diagnosis, were predictive of greater levels of
intrusive distress and avoidance one month after surgery (p<0.05). Patients rating of
'trait' levels of negative emotional expression were not found to be predictive of stress
response assessed using the IES. Previously it has been suggested that suppression of
negative emotion is linked to a type 'C', or cancer-prone personality (Eysenck, 1994).
An alternative explanation is presented in relation to models of understanding
individuals responses to traumatic distress (see Joseph, Yule & Williams, 1997), which
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suggest that attempts to control expression of emotions may be related to attempts to
contain emotional distress. Findings of the present study suggest that those patients
who experience high levels of emotional distress at the time of diagnosis, but who
attempt to suppress those feelings, may be those most likely to continue to show
evidence of symptoms of intrusive distress and of avoidance/emotional numbing
associated with traumatic stress response one month after surgery. There is strong
evidence from the trauma literature that for recovery from exposure to a traumatic event
to occur, the experience must be assimilated within existing mental frameworks or
schemata. Patients who suppress their expression of negative emotions may therefore
be finding it more difficult to come to terms with breast cancer diagnosis or the effects of
treatment. Consistent with this was the finding that self-report of attempts to suppress
negative emotion among patients assessed one week after diagnosis predicted higher
levels of dissatisfaction with outcome of treatment after surgery in relation to body
image (p <0.05). This finding appears to be independent of extent of surgery, since no
difference was found between BC and mastectomy patients in relation to levels of body
image satisfaction post-surgery (see earlier discussion under Body Image heading).
Facilitating expression of emotion is recognised as a key component of psychosocial
interventions (Stanton et al, 2000). Women who are helped to express their feelings,
especially those experiencing higher levels of distress surrounding diagnosis, may
therefore do better in terms of psychological adjustment, although longer term follow up
is required to clarify the relationships between emotional expression and emotional
control and adjustment processes.
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4.2 Methodological Limitations of the Present Study
Sample
Sample size
The principal limitation of the present study was the relatively small sample size (A/=25).
Despite the small sample, evidence of an acute stress response was demonstrated
amongst patients recently diagnosed with early stage breast cancer in this study,
consistent with reports from at least one other study using a much larger sample
(Tjemsland et al 1996). The findings of the present study failed to support any evidence
of better psychosocial outcome for patients who had undergone breast cancer surgery
versus mastectomy. This finding is consistent with those reported elsewhere in the
literature (see Moyer, 1997).
Representativeness of sample
The sample comprised consecutive cases of women attending two specialist breast
units. All patients who met the inclusion criteria were asked to take part in the study.
Information obtained for the study sample on patient demographic variables in terms of
disease and treatment related variables would suggest that the sample were
representative of this patient population. The proportion of women in the sample who
had presented to the clinic through screening (40%) is similar to the proportion of
women amongst whom breast cancers are currently detected. The majority of patients
in this study had invasive cancers (N =22), of which 17 were of NST and five of which
were special types (lobular N = 2, tubular N =3). DCIS was recorded in 3 cases. The
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proportion of patients in each group are thus are comparable with those routinely
presenting at specialist breast clinics (Dixon & Sainsbury, 1998). The mean age of
patients in this sample was 58 years, consistent with peak incidence of breast cancer in
women aged 55-60 years (Watson, 1991).
Timescale
Fewer patients than initially anticipated were recruited for the study. One reason for this
was that at the time when the study was planned, a screening programme had just
ended and it was expected that a high numbers of new patients would be attending the
clinic at QMH. Unfortunately the study was unable to start until several months after this
time due to requirements for Fife Health Board ethics submissions. The number of new
patients routinely presenting at this clinic each week is variable, and not all of those
who were suitable for study inclusion agreed to take part. For this reason the study was
extended to Lothian Health Board in order to try to recruit additional number of patients
attending the WGH clinic, which has a larger clinic with a higher number of routine
referrals per year. Although the recruitment problem was identified a few weeks after
the study commencing at QMH in late January, the process of extending the study to
another area took several months, again due to requirements for ethical approval which
was sought before approaching the hospital and requesting permission from the
Consultants and Breast Care Nurses at the WGH to access their patients. Recruitment
of Lothian patients therefore did not begin until May 2001.
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Rates of Participation in Study
Data from previous studies investigating psychosocial outcome of breast cancer have
tended to include psychosocial measures within larger, controlled treatment trials,
therefore have achieved high rates of participation. Previous research has
demonstrated that there are few differences in characteristics of breast cancer patients
who participate and those who refuse to participate in clinical trials (Brewin & Bradley,
1989). In relation to the present study, it is possible that the type of study (i.e.
investigating psychological aspects of cancer) may have resulted in sample bias.
Patients who were more distressed by diagnosis may have been more likely to take part
in this kind of study. On the other hand, those patients who considered that they were
coping well may have been more likely to agree take part. Several patients mentioned
that feeling they were able to help others in some way or to contribute to research
actually increased their feelings of control. Attention has previously been drawn to the
feelings of lack of control evoked by cancer diagnosis (Ell et al, 1989). The two patients
who withdrew from the study after receiving their results of surgery were extremely
distressed by the results and the implications for their prognosis and treatment. Stanton
et al (2000) suggest that patients expectations of treatment are a crucial factor in
determining outcome.
In retrospect, additional numbers of patients may have been recruited for this study if
patients had been introduced to the study after attending their final staging appointment
at the clinic, for example, if it had been possible to assess patients on the ward the day
before surgery. Patients attending the clinic on the day of that their final staging results
were generally very anxious, and it is likely that in the previous week concerns were
predominated by awaiting the results of their treatment.
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Critique of Measures Used
The measures used in this study are discussed in relation to their potential clinical use
in routine monitoring of psychological adjustment of breast cancer patients, and in
terms of further work required to validate their use as research measures.
HAD
The HAD has been widely used in out-patient medical populations, and provides a brief
measure of anxiety and depression which may be useful for screening or monitoring of
psychological distress. The HAD is already in routine use in Breast Care Units for
monitoring patients levels of psychological distress over the course of treatment.
IES
The IES has proved to be a sensitive measure for detecting psychological stress
responses in cancer patients (Kaasa et al, 1993). The IES is a brief measure, and
results of this study suggest that it may be useful to include this in routine assessment
of breast cancer patients in order to identify those patients who are experiencing
significant levels of traumatic stress. Further research including longer term follow up
using larger samples is required to validate its clinical use with this population however.
BIS
The BIS is a brief, 10 item questionnaire. The results of this study suggest that it would




The MAC is widely used a research tool to assess coping responses of cancer patients.
As the MAC is a 40-item scale it is fairly lengthy to complete and to score. Patients in
this sample found some items difficult to rate using the rating key provided. Patients
assessed soon after diagnosis may have already had fairly lengthy clinic appointments
during which their levels of anxiety were quite high whilst waiting for their results. It was
therefore sometimes difficult for them to concentrate on this questionnaire. Studies
have shown that responses assessed using the MAC are similar to assessment of
coping conducted through clinical interview (Greer et al, 1989). It is likely that in routine
clinical practice it may be more helpful to ask patients for information about their beliefs
and attitudes towards cancer, and their coping responses than to use this kind of scale,
which has been designed mainly for research purposes. Items assessing hopelessness
on this scale may be useful to incorporate into clinical interview however, given that
these items have been associated with evidence of poorer adjustment, in particular
depression (Watson et al, 1988b).
BES
The BES is a recently developed measure designed for research with both normal and
psychiatric populations. It has been noted that measures devised for use with
psychiatric populations often do not translate weil to research with non-psychiatric
populations (Watson, 1991). Further research is required to validate the use of this
scale with cancer patients.
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4.3. Implications of Findings for Psychosocial Care of Breast
Cancer Patients
Patients in this study generally reported that they felt their doctors had taken time to
explain their results and to discuss their treatment with them, and appreciated the
opportunity to have their relative or friend present during the consultation with the
doctor. Partners and family members also appreciated this, as it helped them to feel
more involved to understand aspects of the disease and its treatment better, therefore
offer more support. Several previous studies have highlighted that partners and families
can often feel 'helpless' at this time, therefore this is an important aspect of patient
psychosocial care. Patients and their relatives also appreciated making contact with a
specialist breast care nurse whom they were able to contact by telephone.
The delivery of information in a caring and sensitive manner may provide one of the
most important sources of emotional support for patients. It is therefore vital that
doctors are trained in the necessary communication skills to elicit patients needs for
support and to respond appropriately to them (Fallowfield & Clark, 1991). Doctors and
medical staff have a key role in establishing good communication and offering support
to women around the time of diagnosis, which may help to alleviate distress
surrounding diagnosis, and may have been associated with lower distress at follow up
after surgery found in this sample.
The preliminary results of this study suggest that expression of negative emotion may
reduce anxiety or psychological distress. Helping patients to express negative emotions
is a key component of most psychosocial interventions. The form in which these
interventions may be appropriate for different patients may vary, but it is important that
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all patients have access to a range of resources. The importance of patients
understanding what has happened to them and being supported and reassured by
others that their reactions are normal or otherwise has been emphasised (Wortman &
Conway, 1985). Patients who receive strong and consistent emotional support are
thought to adjust more successfully overtime (Dinkel-Schetter, 1984). Different sources
of support such as family and friends, or doctors often provide different types of support
(Rowland, 1990). By allowing patients to express their concerns, family and friends can
acknowledge and help patients to manage fears (Slevin, Nichols, Downer et al, 1996).
In one study which looked at ' helpful' and 'unhelpful' responses to cancer patients
(Dunkel-Schetter, 1984), 'help' most often meant emotional support, and was perceived
as most supportive when given as a combination of information and direct help.
Blanchard et al (1990) have shown that information giving by physicians is an important
predictor of satisfactory emotional support in cancer patients. Results of a study that
included 431 cancer patients attending out-patient oncology, radiotherapy and
haematology clinics (Slevin, Nichols, Downer et al, 1996) found that the majority of
patients (86%) were satisfied with emotional support provided by their doctors and
nurses. Patients who expressed dissatisfaction with their emotional support were more
likely to be anxious or depressed.
Many patients assessed soon after diagnosis and following surgery commented on the
excellent levels of support provided by the clinic team, and by the nursing staff whilst
they were in hospital for their operations. Patients who were assessed at follow up one
month after surgery were generally less distressed than when seen at the clinic, but
continued to express concerns about aspects of treatment, including worries about
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effects of adjuvant treatment and fears of recurrence. It is likely that the concerns
experienced by women at different stages of treatment may change, and it is important
that women have access to information and sources of support during this time.
Specialist Breast Care Nurses therefore have a crucial role in monitoring distress and
providing support to improve the psychosocial outcome of the disease (Carroll, 1998).
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4.4 Conclusions and Directions for Future Research
Patients in this sample showed evidence of acute stress response associated with
diagnosis. The results of the study indicate that diagnosis of life-threatening disease is
associated with considerable distress, but that in most cases this distress tends to be
transient. At follow up one month after surgery, none of the patients in this sample
experienced clinically significant levels of depression or anxiety. Evidence of stress
response continued to be shown in a proportion of patients, however. Further follow up
of these patients is required to monitor the course of stress response in this population.
Several studies have indicated that substantial distress may be associated with effects
of adjuvant treatment, therefore it may be especially important to monitor patients
psychological reactions more frequently during the first year after diagnosis.
To date only one other longitudinal study has investigated acute stress response in
breast cancer patients. Stress response may be an important predictor of adjustment,
but as yet insufficient information is available regarding changes in stress response
patterns throughout treatment. Intrusive thoughts and avoidance have been
conceptualised as mechanisms by which stress associated with diagnosis or treatment
can have a continuing impact of levels on psychological distress experienced by cancer
patients, and may occur even long after treatment has ended (Baum, Cohen & Hall,
1993; Greenberg, Kornblith, Herndon et al, 1997). A relationship between stress
response measured with the IES and psychological distress amongst cancer patients
has been reported amongst patients with varying diagnoses and disease stages
(Epping-Jordan, Compas & Howell, 1994), including breast cancer patients (Baider &
DeNour, 1997; Vickberg, Bovbjerg, DuHamel et al, 2000). Improved understanding of
possible phase specific responses is of potential clinical importance, in order to ensure
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that additional resources are targeted effectively towards patients at these stages of
treatment. Longer term follow up using larger samples of patients are required to further
assess the relationship between stress response and psychological adjustment to
breast cancer.
Given the high levels of anxiety and traumatic stress associated with investigation of
breast cancer, it is important that ways to reduce distress for patients at this time are
identified. The time waiting for results of investigations and for surgery was described
as one of the most stressful aspects of the experience by patients assessed before and
after surgery. Several patients at one of the clinics mentioned waiting times for their
appointment as a source of considerable distress, especially once diagnosis was
confirmed which resulted in worries that cancer may have 'got worse' during the time
between finding a lump and having their investigations carried out. This is clearly an
unacceptable cause of additional anxiety amongst breast cancer patients. Waiting times
for clinic appointments vary nationally and regionally. In response to issues of waiting
time for cancer referrals, the Government last year introduced a two week rule for GP
referrals. Due to resource constraints, it has been impossible for specialist cancer units
in many areas to meet this demand (Jones, Rubin & Hungin, 2001). Although there is a
view that this goes beyond the evidence base, delays of to 3-6 months in breast cancer
patients are associated with reduced survival (Richards, Westcome, Love, et al, 1999).
Increasing demand for patients to be seen earlier, and for results to be available more
quickly means that additional resources are required to be in place. It is likely that these
issues have a major impact of aspects in relation to levels of patient distress.
With regard to studies comparing the psychosocial outcome of breast cancer surgery,
relatively few studies to date have provided baseline data by which to assess specific
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treatment effects on aspects of body image satisfaction or in relation to other measures
of psychological adjustment. The results of this study highlight the importance of
obtaining baseline measures. As previously concluded by other reviewers (Carlsson &
Hamrin, 1994; Fallowfield & Clark, 1992; Moyer & Salovey, 1997) failure to demonstrate
significant differences in levels of psychological distress between patients undergoing
BC surgery and mastectomy underlined the need for psychosocial support to be
available to all breast cancer patients. It is hoped that in the future, outcome of breast
cancer treatment will be improved through the advent of newer, less aversive
treatments (Fallowfield & Clark, 1992). The advent of potential new drug treatments for
breast cancer continues to receive substantial media attention (Tait, 1996), and breast
cancer remains and emotive topic. Whilst new treatments offer many more possibilities
for breast cancer treatment in the future (see recent copy of recent newspaper article
included in Appendix 3), new challenges are raised regarding involvement of patients in
aspects of treatment decision-making and choice, and regarding expectations of
treatment. Given the high levels of distress associated with diagnosis of breast cancer,
concerns have been expressed regarding patients' reduced capacity for information
processing and decision making at this time. Provision of balanced information given in
a sensitive manner, and time allocated to discuss various options with patients is
therefore crucial, given that various treatments available may be associated with a
range of different temporary or permanent effects, and there may be variations in the
duration of treatments. Recent studies comparing effects of breast cancer treatments
including surgery ( Stanton et al, 2000: Nissen et al, 2001) have highlighted the many
individual factors that need to be taken into account in relation to issues of optimal
patient matching with appropriate treatment based on medical criteria and taking into
account the patients wishes.
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"PSYCHOLOGICAL IMPACT OF DIAGNOSIS AND SURGERY
IN THE TREATMENT OF EARLY STAGE BREAST CANCER"
BREAST UNIT, WESTERN GENERAL HOSPITAL, EDINBURGH
PATIENT INFORMATION SHEET
This leaflet tells you about the study which you have been asked to take part
in. Please read this carefully before deciding whether or not you wish to take
part. Remember to take the information sheet with you when you leave today.
What is the study about?
We are keen to find out more about the psychological impact of diagnosis and
of surgery in the treatment of early stage breast cancer. To help us with this,
we would like to speak to women who have recently been diagnosed with
breast cancer, to ask about their feelings about diagnosis and about how they
are coping with this experience. We will then follow up patients who are seen
at this stage a few weeks after their surgery. As part of the study, we would
also like to ask patients about the support available to them at this stage of
their investigations and treatment.
Who is carrying out the study?
The study is being carried out by Elaine Johnston, who is a final year trainee
on the doctoral training course in Clinical Psychology at the University of
Edinburgh. The study is being carried out as part of a doctoral thesis
Who is being asked to take part?
Patients attending the clinic who are being considered for surgery will be
invited to take part in the study.
Do I have to take part?
No. Participation in the study is entirely voluntary. If you decide not to take
part, this will not affect your treatment in any way.
What will the study involve?
If you agree to take part in the study, you will be seen for a brief appointment
when you come back to the clinic on Tuesday next week, in order to complete
a few short questionnaires. This should take no more than 20-30 minutes, and
will be arranged to take place at some point during the morning while you are
waiting to see the doctors and nurses at the clinic.
You will be contacted to arrange a follow-up appointment a few weeks after
your operation, which can be arranged to take place either at the clinic, or at
your home if you prefer. The follow up appointment will again involve a short
interview and completing a few questionnaires.
Will my information be confidential?
Yes. The information you provide will be treated as strictly confidential, and
will not be passed on to anyone without your prior consent. This means that
the hospital staff will not have access to this information, and it will not be
used to inform any decisions about your treatment. The results of the study
will be reported anonymously, so that it will not be possible to identify
individual patients.
Patient Ethics
This study has been approved by the Ethics Committee of Lothian Health
Board. The local independent advisor for the project is Dr. Aileen Thomson,
Chartered Clinical Psychologist, who can be contacted at the Astley Ainslie
Hospital on 0131 537 9125 in case of any queries or complaints which you do
not feel have been addressed by the researcher.
Further questions?
If you have any other questions about the study before deciding whether you
wish to take part, or would like to discuss the study informally, please ask to
speak to Elaine Johnston, who will be available at the clinic on Tuesday, or
can be contacted at the University of Edinburgh on 0131 537 6279 (please
leave message with secretary).
Thank you for taking the time to read this leaflet!
You will be asked whether or not you wish to take part in this
study when you attend your appointment at the clinic on
Tuesday. It would help the researcher if you could let us know
if you are interested by handing in the attached form when




"PSYCHOLOGICAL IMPACT OF DIAGNOSIS AND SURGERY
IN THE TREATMENT OF EARLY STAGE BREAST CANCER"
BREAST UNIT, WESTERN GENERAL HOSPITAL, EDINBURGH
I am / am not * interested in taking part in this study.
(*please delete as appropriate)
Name:
Appendix 2
IMPACT OF EVENT SCALE
MARDl HOROWITZ el at.
Name Date Completed
Therapist/Interviewer
I On vou experienced
j (date) (life event)
Below is a list of comments made by people after stressful life events. Please check each item, indicating how
frequently these comments were true for you DURING THE PAST SEVEN DAYS. If they did not occur during that
time, please mark the "not at all" column.
FREQUENCY
Not at All Rarely Sometimes Often
1.1 though' about it when 1 didn't mean to.
2. 1 avoided letting myself get upset when 1 thought
| about it or was reminded of it.
3. i tried to remove it from my memory.
4. 1 had trouble railing asleep or staying asleep,
! because of pictures or thoughts about it that came
into my mind.
5 1 had waves of strong feelings about it.
6. 1 had dreams about it.
1 7. 1 stayed away from reminders of it.
8.' 1 felt as if it hadn't happened or it wasn't real.
9. 1 tried not to talk about it.
10. Pictures about it popped into my mind.
I 11. Other thinqs kept making me think about it.
12. I was aware that I still had a lot of feelings about it,
| but I didn't deal with them.
13. I tried not to think about it.
14. Any reminder brought back feelings about it.
| 15. My feelings about it were kind of numb.
Below to be completed by therapist:
Intrusion subset = 1,4,5,6,10,11,14. Avoidance subset = 2,3,7,8,9,12,13,15.
OVERALL





Health 13 Social Care
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)ate: Record Number:
5TRUCTIONS: A number of statements are given below which describe people's
ictions to having cancer. Please circle the appropriate number to the right of each state-
snt, indicating how far it applies to you at present. For example, if the statement definitely
es not apply to you, then you should circle 1 in the first column.
I feel I can't do anything to cheer myself up.
I feel that problems with my health prevent me
from planning ahead.
I believe that my positive attitude will benefit my
health.
I don't dwell on my illness.
I firmly believe that I will get better.
I feel that nothing I can do will make a difference.
I've left it all to my doctors,
feel that life is hopeless.
I have been doing things that I believe will improve
my health e.g. exercising.
Since my cancer diagnosis, I now realize how
precious life is and I'm making the most of it.
I've put myself in the hands of God.
I have plans for the future e.g. holiday, jobs,
housing.
I worry about the cancer returning or
getting worse.
I've had a good life; what's left is a bonus.
I think my state of mind can make a lot of
difference to my health.
feel that there is nothing I can do to help myself.
Definitely Does not
does not apply
I have been doing things that I believe will improve



















































Definitely Does not Applies Definitely
does not aPP'y to me applies
apply to me to me
* me
18. I try to carry on my life as I've always done.
19. I would like to make a contact with
others in the same boat.
20. I am determined to put it all behind me.
21. I have difficulty in believing that this happened to
me.
22. I suffer great anxiety about it.
23. I am not very hopeful about the future.
24. At the moment I take one day at a time.
25. I feel like giving up.
26. I try to keep a sense of humour about it.
27. Other people worry about me more than I do.
28. I think of other people who are worse off.
29. I am trying to get as much information as I can
about cancer.
30. I feel that I can't control what is
happening.
31. I try to keep a very positive attitude.
32. I keep quite busy, so I don't have time to think
about it.
33. I avoid finding out more about it.
34. I see my illness as a challenge.
35. I feel fatalistic about it.
36. I feel completely at a loss about what to do.
37. I feel very angry about what has
happened to me.
38. I don't really believe I had cancer.
39. I count my blessings.

































































©Watson, Greer and Bliss, 1989. Reproduced with the kind permission of the authors.
This measure is part of Measures in Health Psychology: A User's Portfolio, written and compiled by Professor John
Weinman, Dr Stephen Wright and Professor Marie Johnston. Once the invoice has been paid, it may be photocopied
for use within the purchasing institution only. Published by The NFER-NELSON Publishing Company Ltd, Darville
House, 2 Oxford Road East, Windsor, Berkshire SL4 1DF, UK. Code 4920 04 4
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Body Image Questiormafre
In this questionnaire you will be asked how you feel about you appearance, and
about any changes that may have resulted from your disease or treatment Please
read each item carefully, and place a firm tick on the line alongside the reply which
comes closest to the way you have been feeling about yourself, during the past
week.
Not at A little Quite Very
all a bit much
Have you been feeling self-conscious about
your appearance ?
Have you felt less physically attractive as a
result of your disease or treatment ?
Have you been dissatisfed with your
appearance when dressed ?
Have you been feeling less feminine/masculine
as a result of your disease or treatment ?
Did you find it difficult to look at yourself naked ?
Have you been feeling less sexually attractive
as a result of your disease or treatment ?
Did you avoid people because of the way you
felt about your appearance ?
Have you been feeling the treatment has left
your body less whole ?
Have you been dissatisfied with your body ?
Have you been dissatisfied with the appearance
of your scar? m/a
r\r o rcjr Pcurhohmoi Orouo Stantev House. ChnsDa Hosoital. Wilmsiow Road. Wihtnqton. Mancfrestpr,
THE BASIC EMOTIONS SCALE
The purpose of this scale is to find out about how much or how often you experience certain emotions, and then to
ask some questions about how you feel actually during particular emotions themselves.
The first part of the scale is designed to explore how you have felt DURING THE LAST WEEK.
For each emotion, please circle ONE number only between 1 and 7, to indicate how you have felt.














































In the second part of this questionnaire we would like to know about how you feel IN GENERAL. The question
asks about HOW OFTEN you feel the emotion. Again, for each question please circle ONE number only between 1
and 7 to indicate how you feel.














































In the third part of this questionnaire we would like to ask you for some information about HOW YOU FEEL
when you experience that emotion. Please note: even if you never experience a particular emotion, please answer
the question by imagining how you think you would feel if you did experience that emotion. Again, for each part of
the question, please circle ONE number between 1 and 7 to indicate how you feel.















































Thank You Very Much For Your Help With This Questionnaire
Appendix 3






EARLY tests of a revolutionary
drug and radiation cancer treat¬
ment invented by British scien¬
tists have proved dramatically
successful, it was revealed
yesterday.
Laboratory mice genetically
engineered to grow human
tumours were completely cured
in 85 per cent of cases-
More than nine months after
• the treatment was stopped
there was no evidence of any
residual cancer in the animals.
One half of the treatment
consists of a drug called Com-
bretastatin - based on a tree-
bark extract used by Zulu
warriors as a charm to ward off
their enemies - which targets
newly-forming blood vessels
that nourish tumours.
The other comprises anti¬
bodies tagged with a radio¬
active "warhead" which they
ferry into cancer cells.
The tfierapy was pioneered
by Cencer Research Campaign
scientists at the Royal Free Hos-
Eital in London and the Grayiboratory Cancer Research
•Trustat" " " " "" *' *
Human clinical trial; are
expected to begin next year. If
successful they could lead to the
treatment being available in
five years.
Professor Richard Regent,
head of oncology at the Royal
Free, said: "Combretastatin has
been given to patients on Its
own before but the response
has not been very good In most
cases, the cancer continues to
grow. But when you put the two
.^treatments together it's then
possible in these animals to
cure the cancer completely with
just a single treatment
"It is rather exciting. We're
now working towards carrying
out some clinical trials with the
Cancer Research Campaign."
Tumours cannot live without
blood and generate their own
special network of blood vessels
to provide an adequate supply.
Combretastatin specifically tar¬
gets and cuts off the cancer
blood network by binding on to
the dividing cells creating the
new capillaries.
Researchers found a ring of




do not rely on the cancer blood
supply system - they use normal
blood vessels instead - and are
thus free to keep growing.
The antibodies tackle these
by zapping them with radio¬
active material.
The experiments at the Royal
Free Hospital were led by Dr
Barbara lYdley. head of tumour
biology at the Cancer Research
Campaign's targeting and
imaging group.
Dr Pedley said: "We are
"
exrite^b^ tficse .result*. These
are humin tumours grown in
mice.
"Although we have been
mainly looking at colorectal
cancer, it works on a very wide
range of cancers - all the solid
tumours, which includes breast
cancer."
The key to the therapy is that
it ensures that no residual
cancer is left
Combretastatin attacks the
tumour from the inside out by
cutting off its blood supply. The
radioactive antibodies work
from the outside in.
Excitement about Combre-
tastatin begin four years ago
wheniCaltKer Research Cam¬
paign Scientists found it could1dH up to 95 per cent of cells in
solid tumours in the laboratory.
Vitamin C can Inertag«
the risk af cancar Page 6
However, in patients, the small
number of cancer cells left
behind allowed the disease to
return.
Dr Lesley Walker, director of
cancer information at the Can¬
cer Research Campaign, said:
This good news confirms what
we have been saying all along -
that treatments that directly
target cancers and spare normal
tissue will be the cancer ther¬
apies of the future.
"By combining radioimmuno-
therapy with Combretastatin.
doctors could in the future be
able to launch a two-pronged
attack on the cancer cells, effec¬
tively delivering a 'double-blow'
and preventing tumours from
rcjpowing.
As well as improving the
effectiveness of treatment, it
should greatly reduce side-
effects for the patient.'
Dr Walker said patient trials
involving Combrctastarin were |
due to start early next year and a ,
number of trials were expected j
to use a combination of the I
drug in conjunction with other
chemotherapy agents and/or (
radiotherapy.
About 200 patients with a
variety of different cancers
would be recruited
